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ABSTRACT 
The aberrant regulation of cell cycle checkpoints can potentially initiate cellular 
transformation to an oncogenic state that leads to tumor formation. Many families of cell 
cycle regulators are present to ensure that normal cellular growth and replication occurs, 
including the polo-like kinases (Plk). Plk4 (Sak), the newest and most structurally 
divergent member of the Plks has been implicated to play crucial roles in centrosome 
dynamics and mitotic progression. Plk4 heterozygous mouse embryonic fibroblasts 
(MEFs) present a number of phenotypic differences, in comparison to their wild type 
counterparts that may contribute to the increased incidence of tumor formation observed 
in heterozygous Plk4 mice. Microarray technology was employed to investigate 
transcriptional differences between the wild type and heterozygous Plk4 MEFs. 
Furthermore, transcriptional and protein differences were examined in the Plk4 MEFs in 
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Chapter 1 
Review of Literature 
General Introduction 
The progression of the cell cycle is tightly regulated to ensure proper integrity of 
the DNA information and to provide that the genetic material is passed on to viable, 
normal daughter cells. The integrity of the genetic material is protected by cell cycle 
checkpoints (Elledge, 1996). These checkpoints halt the cell cycle if the DNA has been 
damaged or mutated in response to genotoxic stress. Aberrant regulation or loss of one of 
these checkpoints can results in errors in DNA replication or in chromosomal 
segregation, leading to aneuploidy or polyploidy, predisposing cells to genetic instability 
(Xie et al., 2005). This genetic instability can lead to uncontrollable, rapid cellular 
proliferation which can eventually form cancerous tumors. The cell cycle is tightly 
controlled, with built-in redundancies that are designed to ensure fidelity. The focus of 
my research is on Plk4, a member of the polo like kinase (Plk) family of serine/threonine 
kinases, which have been shown to control a multitude events throughout the cell cycle 
(Xie et al, 2005). 
Polo like Kinase Family 
The polo like kinases (Plks) are an evolutionary conserved family of cell cycle 
regulators (Dai, 2005). The founding member of the Plk family, Polo was first discovered 
in Drosophila melanogaster (Sunkel et al, 1988) and was shown to be serine/threonine 
kinase crucial for mitosis (Glover et al, 1993). Mutations in the Polo gene lead to 
abnomalities in spindle pole formation leading to abnormal mitotic division (Glover et al, 
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1998). Subsequently homologues have been characterized in simple single celled 
organisms such as yeast to more complex organisms such as mammals. The family, as a 
whole, plays key roles in the regulation of the cell cycle and DNA damage pathways. The 
budding yeast, Saccharomyces cerevisae, and the fission yeast, Schizosaccharomyces 
pombe (Ohkura et al., 1995), contain one Plk homologue, Cdc5 (Golsteyn et al, 1996), 
and Plol (Ohkura et al, 1995) respectively. Drosophila contains two Plk homologues, 
Polo (Fenton and Glover, 1993) and Plk4 (Lowery et al, 2005), while the nematode, 
Caenohabditis elegans contains three Plk homologues, Plcl, Plc2 (Ouyang et al, 1999), 
and Plc3 (Chase et al., 2000). Both Xenopus laevis and mammals contain four Plk 
homologues. In Xenopus, Plxl (Kumagai andDunphy, 1996), Plx2 (Duncan et al., 2001), 
Plx3 (Duncan et al., 2001), and Plx4 (unpublished data) have all been identified while in 
mammals, Plkl (Golsteyn et al, 1994), Snk/Plk2 (Donohue et al, 1994), Prk/Fnk/Plk3 
(Donohue et al, 1995) and Sak/Plk4 (Fode et al, 1994) have been characterized. The 
increase in number of Plk members in more complex organisms is likely a reflection of 
the need for tighter controls for cell cycle regulation inherent with multicellularity. Plks 
possess many unique functions throughout the cell cycle including events critical for cell 
division, centrosome duplication and maturation, DNA damage checkpoint activation, 
mitotic onset, bipolar spindle formation, Golgi fragmentation and assembly, chromosome 
segregation, and cytokinesis (Dai, 2005). 
Plk Structure 
The Plk family consists of catalytic domain at the N-terminus and a one or two 
polo box domains at the C-terminus of the protein (Dai, 2005) (Figure 1). The catalytic 
2 
Polo Box Domain 
Kinase Domain Polo Box 1 Polo Box 2 








Figure 1: Structural Comparison between Plk4 and of other Plk Family Members 
Members of the Plk family all contain a highly homologous kinase domain at the N-
terminus and one or two polo box domains at the C-terminus of the protein. Plk4 differs 
from the other Plks as it contains only one polo box domain. Upstream of Plk4s polo box 
domain is also a region depicted as the cryptic polo box domain. In addition, Plk4 as 
contains three PEST sequences associated with reduced protein stability. 
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domain of the Plks contains their kinase activity and is highly homologous in all Plks. 
The polo box domain located at the C-terminus of the protein has been shown to regulate 
cellular functions (Seung et al., 2002), subcellular localization (Elia et al., 2003), and 
provide a docking site for protein-protein interaction (Reynolds et al., 2003). Plk4 differs 
from the other Plks in respect to the polo box domain as it contains only one domain. 
Upstream of the polo box domain, Plk4 contains a cryptic polo box domain, which along 
with the polo box domain serves as self association domains (Leung et al., 2002). In 
addition, Plk4 contains 3 PEST sequences which are commonly associated with reduced 
protein stability and this is the case with Plk4 as it displays a short half life of only two to 
three hours in non-synchronized cells (Fode et al., 1996) (Figure 1). Though Plk4 
contains significant sequence homology to the other Plks in its kinase domain, Plk4 
appears to have diverged from a primordial polo-like kinase early in the radiation of 
metazoans in respect to the rest of its structure (Hudson et al., 2001). 
PIk Expression and Localization Profiles 
a) Unicellular organisms and invertebrates: The mRNA and protein levels of the Plk 
family are regulated in a cell-cycle dependent manner. The yeast Plks, Cdc5 and Plol, in 
Saccharomyces cerevisiae and Schizosaccharomyces pombe respectively, both localize 
to the spindle pole bodies, although the timing of localization differs within the cell cycle. 
Cdc5 localization to the spindle pole bodies occurs in Gi and persists until late mitosis 
(Song et al., 2000). Conversely, Plol localizes to the spindle pole bodies at the G2/M 
transition when Cdc2 is active and subsequently dissociates from the spindle pole bodies 
during anaphase upon Cdc2 inactivation (Mulvihill et al., 1999). Both yeast Plk 
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homologues also localize to the cytokinetic ring structures, and play a role in cytokinesis. 
Cdc5 localizes to the septin ring during G2 and remains activated until late mitosis 
(Sakchaisri et al., 2004), whereas Plol localizes to the medial ring structures when they 
are formed (Bahler et al., 1998). 
The Drosophila Plk homologue, polo localizes to the centrosomes during the G2/M 
transition and then associates with the nuclear membrane until its breakdown. During 
prometaphase, polo localizes to the kinetochores and prior to cytokinesis at the mid-part 
of the central spindle, a structure essential for cytokinesis (Moutinho-Santos et al., 1999). 
In all organisms within the Animal kingdom, Plk homologues follow similar 
patterns of subcellular localization (Glover, 2005) with localization of the protein a 
reflection of the different role the respective protein plays throughout the cell cycle. In 
the following sections I will discuss this for Plksl-3. Plk4 will be discussed in detail 
individually. 
b) Mammalian Plks: In humans Plkl expression increases from late S phase onward 
and peaks in mid mitosis at which point Plkl activity is greatest. Plkl is then targeted for 
degradation by the anaphase promoting complex in late mitosis. Plkl expression levels 
are high in proliferating tissue such as the testis, spleen and thymus (Golsteyn et al., 
1994). Plkl localizes to many cellular structures throughout the cell cycle, in accordance 
with the many functions Plkl performs. Plkl localizes to the nucleus and cytoplasm 
during G2, though its localization is specifically targeted to the centrosomes. In early 
mitosis, Plkl is present at the centrosome and kinetochores, while in late mitosis Plkl 
localizes to the spindle midbody (Golsteyn et ah, 1995). The polo box domain is essential 
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for targeting Plkl to these subcellular structures as well as to interacting partners 
throughout the cell cycle (Elia et al., 2003). 
Whereas Plk2 displays significant homology to Plkl, its function and tissue 
distribution differ greatly. Plk2 has been identified as an early response gene with mRNA 
levels peaking in response to mitogens. Plk2 primarily functions as a regulator of cell 
proliferation in Gi (Simmons et al., 1992). Upon its activation at the Gi/S transition, Plk2 
localizes to the centrosomes, indicating a role for Plk2 in centriole duplication (Warnke et 
al., 2004). A role for Plk2 later in the cell cycle may also be plausible. In response to 
genotoxic stress causing mitotic spindle damage, Plk2 expression was able to prevent 
mitotic catastrophe (Burns et al., 2003). Whereas no Plkl activity was detected in the 
brain, Plk2 is constitutively expressed in the post-mitotic neurons of the brain indicating 
Plk2 mediates phosphorylation of proteins within the neurons (Kauselmann et al., 1999). 
Similarly to Plk2, Plk3 was identified as an immediate early response gene with 
mRNA levels peaking after the addition of mitogens (Donohue et al., 1995). Like Plk2, 
Plk3 also displays a broad distribution of tissue specificity (Holtrich et al., 2000). Plk3 
expression is relatively low during mitosis, Gi, the Gi/S transition, and peaks during late 
S phase and G2 (Ouyang et al., 1997). Discrepancies have emerged over the localization 
pattern of Plk3 throughout the cell cycle. Previous work has shown that Plk3 localization 
is polo-box mediated and that Plk3 localizes to the centrosomes, spindle poles, and the 
spindle midbody (Jiang et al, 2006). In contrast, Zimmerman and Erikson, 2006 found 
that Plk3 localized exclusively to the nucleolus and suggested a role for Plk3 in the Gi/S 
transition. In this study, Plk3 expression was undetectable during mitosis. Similar to Plk2, 
Plk3 is also expressed in post-mitotic neurons with a possible role in synaptic plasticity 
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(Kauselmann et al., 1999). Interestingly, Plk3 has also been implicated to have a role in 
cellular adhesion (Holtrich et al., 2000). 
Plks and Mitotic Entry 
The transition from G2 to mitosis is a crucial junction in the cell cycle. Aberrant 
regulation of this cellular checkpoint can lead to genomic instability and promote 
oncogenesis. Members of the Plk family play crucial roles at the G2/M cellular 
checkpoint to promote entry into mitosis. Plkl has been implicated to perform numerous 
functions to promote mitotic entry within the cell. For mitotic entry to occur, the Cyclin 
B/Cyclin Dependent Kinase l(Cdkl) complex must become activated. Plkl promotes 
mitotic entry by activating cyclin B/Cdkl at three levels. Firstly, Plkl is able to 
phosphorylate Cdc25C in its nuclear export signal sequence promoting its nuclear 
translocation and activation (Roshak et al., 2000, Toyoshima et al., 2002). Therefore, 
Cdc25C is able to dephosphorylate Cdkl promoting the activation of the cyclin B/Cdkl 
and mitotic entry (Gauthier et al., 1991). Secondly, Plkl phosphorylates both Weel and 
Mytl, both CyclinB/Cdkl-inhibiting kinases. In the fission yeast, Saccharomycespombe, 
Weel is known to phosphorylate Thrl4 and Tyrl5 on Cdc2, the fission yeast homologue 
of Cdkl. Though in mammals, Weel phosphoryation only occurs on Tyrl5 (McGowan et 
al., 1993). Phosphorylation of Weel by Plkl leads to Weel enhanced association with 
the SCF/beta-TrCp E3 ubiquitin ligase, inducing its degradation (Watanabe et al., 2004). 
Phosphorylation of Thrl4 by Mytl is the additional phosphorylation that serves to inhibit 
the activity of Cdkl (Lui et ah, 1997). Thirdly, Plkl phosphorylates cyclin B at the 
centrosomes in prophase, this being the first site where cyclin B/Cdkl is actually 
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phosphorylated. Though discrepancy remains whether this phosphorylation by Plkl of 
cyclin B triggers its nuclear import or whether the cyclin B/Cdkl complex is activated in 
a different manner. 
Plxl, the Xenopus laevis homologue of Plkl is shown to stimulate activation of 
cyclin B/Cdc2 complex and regulate mitotic entry through a positive feedback loop. Plxl 
phosphorylates and activates Xenopus polo-like kinase-kinase 1 (xPlkkl). Subsequently, 
xPlkkl phosphorylates and activates Plxl (Qian et ah, 1998). Activated Plxl can 
subsequently phosphorylate and activate Cdc25C which dephosphorylates Thrl4 and 
Tryl5 on cdc2 promoting mitotic entry (Qian et al., 2001). 
Whereas the role of Plkl in mitotic entry has been well described, the role of the 
other Plks at the G2/M checkpoint remains to be elucidated. As Plk2 primarily regulates 
Gi/S progression, it doesn't appear to play a role in mitotic entry (Simmons et al., 1992). 
Although Plk3 does not appear to play a role in mitotic entry, in response to DNA 
damage Plk3 positively regulates p53 activity to halt progression of the cell from G2 to 
mitosis (Xie et al., 2001). 
Plks and their Role in Mitotic Exit and Cytokinesis 
Plks have been shown to play roles in both exit from mitosis and cytokinesis. For 
mitotic exit to occur, the inactivation of Cdkl is required. In budding yeast, inactivation 
of Cdkl occurs after the metaphase/anaphase transition, which differs from mammalian 
cells, where downregulation of Cdkl occurs at the metaphase/anaphase transition (Clute 
and Pines, 1999). The downregulation of Cdkl promotes exit from mitosis, and in 
budding yeast requires the cooperation of the FEAR (Cdc Fourteen Early Anaphase 
8 
Release) (Stegmeier et ai, 2002) and MEN (Mitotic Exit Network) pathways (Bardin and 
Amon, 2001) and Cdc5 plays an important role in regulating both of these pathways. 
Although the role which Cdc5 plays in regulating has yet to be described, it is assumed 
that Cdc5 coordinates between the FEAR and MEN pathways via phosphorylating 
regulatory components in each pathway (Lee et ai, 2005). Cdc5 and additional 
components of the MEN pathway are also required for proper actin ring formation at the 
mother-bud-neck, the site of cytokinesis (Jimenez et ai, 1998). 
In fission yeast, Plol has been implicated in two events regulating cytokinesis. 
First, Plol localizes to the site of cytokinesis, and this localization is important for the 
placement and organization of the actin-based medial ring (Bahler et ah, 1998). 
Secondly, Plol activity correlates with the initiation of septin formation which regulated 
by the septin initiation network (SIN) (Gruneberg and Nigg, 2003). The SIN and MEN 
networks contain structurally related proteins that perform similar functions in each 
pathway. Like Cdc5, the functional significance of Plol role in the SIN pathway has yet 
to be determined. 
In Drosophila, polo has also been implicated as having a role in cytokinesis as it 
directs the function of the Pavarotti-KLP (Pav-KLP) family of motor proteins. This 
family of proteins plays a role in organizing the central spindle in anticipation of 
cytokinesis (Glover, 2005). Polo and Pav-KLP interact and both co-localize to the central 
part of the spindle (Liu et ai, 2004). Interestingly, studies have revealed that proteins 
including Polo, Asp (Wakefield et ah, 2001), and y-TuRC (Sampaio et ah, 2001) are 
involved in the organization of the centrosomes and the early mitotic spindles also 
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perform roles in cytokinesis. It is hypothesized that Polo may phosphorylate these 
substrates at both the beginning and conclusion of mitosis (Glover, 2005). 
In Xenopus, the transition from metaphase to anaphase and therefore exit from 
mitosis requires the activity of Plxl since inhibition of Plxl prevents the metaphase to 
anaphase transition (Qian et al, 1999). The requirement for Plxl activity suggests that 
Plxl may control the anaphase-promoting complex/cyclosome (APC/C). Three possible 
mechanisms have been hypothesized; first, Plxl may activate the APC/C through direct 
phosphorylation of several APC/C subunits (Kotani et al, 1998). Secondly, Plxl may 
regulate the activators or inhibitors of the APC/C (Reimann et al, 2001), or thirdly, Plxl 
could activate the APC/C and prevent premature inactivation of the APC/C (Brassac et 
al, 2000). Additionally, the inactivation of Plxl may be required for the completion of 
cytokinesis to occur (Qian et al., 1999). 
Like Plxl, Plkl may be involved both directly and indirectly in the activation of 
the APC/C. Activation of the APC/C may occur through direct phosphoryation of APC/C 
subunits along with the phosphorylation of the cyclin B/Cdkl complex (Golan et ah, 
2002). Indirectly, Plkl is responsible for activating the APC/C by inducing the 
destruction of APC/C inhibitor "Early mitotic inhibitor 1" (Emil) (Moshe et al, 2004). 
Similar to other Plk homologues, Plkl has also been implicated to play a role in 
cytokinesis. Although the exact role that Plkl plays in cytokinesis is unknown, Plkl has 
been shown to interact with and phosphorylate cytokinetic proteins. Plkl phosphorylates 
the kinesin-like motor protein CHOl/MKLP-1 (Lee et al., 1995), NudC (a component of 
the dynaction complex Zhou et al., 2003), the mitotic kinesin-like protein 2 (MKlp2) 
(Neef et al, 2003), and the Rho exchange factor ECT2 (Niiya et al, 2005). Though the 
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functional significance of some of these interactions remains to be elucidated, 
phosphorylation of NudC and MKlp2 by Plkl are indispensible for the execution of 
cytokinesis. To date, Plk2 and Plk3 have not been implicated in mitotic exit or 
cytokinesis. 
Plks and their Role in DNA Damage Pathways 
The cellular response to DNA damage by genotoxic stress is crucial, as failure to 
repair any damage in the genetic material can produce aneuploidy leading to uncontrolled 
cellular growth and oncogenesis. In response to genotoxic stress, cell cycle checkpoints 
are employed to repair damage that has occurred to the DNA or to initiate apoptosis if the 
damage is irreparable. Plks have been implicated to play crucial roles in the DNA 
damage pathways. 
In response to DNA damage, the DNA damage sensor proteins, ataxia-
telangiectasia mutated (ATM) or ataxia-telangiectasia and Rad3-related (ATR) become 
activated (Bakkenist et al, 2003). Activation of ATM or ATR in response to DNA 
damage inhibits the function of Plkl (van Vugt et al., 2001). The inhibition of Plkl by 
ATM or ATR is mediated by the ATM/ATR downstream effector kinase checkpoint 
kinase 1 (Chkl). Experimentally it has been observed that the inhibition of Plkl is 
rescued in Chkl-depleted cells exposed to UV radiation (Tang et al., 2006). Inhibition of 
Plkl in response to DNA damage prevents it from promoting mitotic entry in the 
presence of genomic instability. Subsequently, Plkl also binds to and phosphorylates the 
tumor suppressor p53 inhibiting its function, thus preventing p53 mediated pro-apoptotic 
pathways. Expression of ATM is able to attenuate Plkl interaction with p53 (Ando et al., 
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2004). Whereas Plkl is able to negatively regulate p53 function, Plk3 positively regulates 
the transcriptional function of p53. In response to DNA damage, ATM phosphorylates 
Plk3 activating its kinase ability and Plk3 then phosphorylates p53 on a different residue 
from Plkl, promoting p53 mediated G2/M cell cycle arrest and apoptosis (Xie et al., 
2001). 
In addition, Plk3 has been implicated to play a role in DNA damage repair. Plk3 
is able to regulate the activity of DNA polymerase 8 (pol 5), a major enzyme in DNA 
damage repair (Hubscher et al., 2002). Plk3 phosphorylates pol 8 on pi25, the major pol 
8 subunit on Ser60. Though the functional significance of this interaction remains to be 
elucidated, it is speculated that since Plk3 phosphorylates pi25 in its nuclear localization 
signal, this phosphorylation controls the subcellular localization of pol 8 (Xie et al., 
2005). 
Plk2 may also play a role in DNA damage pathways. In response to ionizing 
radiation, mRNA transcript levels of Plk2 were shown to increase. This response was 
deemed to be p53 dependent as based on luciferase assay data; a candidate site for a 
radiation response element was mapped to the Plk2 promoter containing a p53 binding 
motif (Shimizu-Yoshida et al, 2001). A subsequent study showed that p53 indeed 
regulates Plk2 in response to genotoxic stress. In response to mitotic spindle damage, 
Plk2 is activated in a p53 dependent manner and this activation prevents mitotic 
catastrophe (Burns et al., 2003) (Figure 2). 
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Figure 2: Role of Plks in the DNA damage Pathways 
In response to either ultraviolet radiation (UV) or ionizing radiation (IR), the DNA 
damage sensor proteins ataxia telangiectesia and Rad3 related (ATR) and ataxia 
telangiectesia mutated (ATM) become activated, respectively. In response to either UV 
or IR damage, Plkl is either inhibited by ATR or ATM. Subsequently, ATR activates 
checkpoint kinase 1 (Chkl), or ATM activates checkpoint kinase 2 (Chk2). Normally, 
Plkl activates cell division cycle 25c (Cdc25c) promoting G2/M transition. Since Plkl is 
inhibited by either ATR or ATM, Cdc25c activity is inhibited by Chkl or Chk2 in 
response to UV or IR, respectively. In response to IR, ATM also activates Plk3, which 
activates DNA polymerase 5, promoting DNA repair. In addition, Plk3 can activate Chk2 
and p53, while Chk2 can also activate p53. The activation of p53 inhibits progression of 
the cell cycle from G2 to mitosis. Plk2 activity is also initiated by p53 in response to 
DNA damage. The role that Plk4 may play in the DNA damage pathways remains to be 
elucidated. Plk4 interacts with ATM, ATR, Chkl, Chk2, p53, and Cdc25c, though the 
functional significance of these interactions remains to be described. Black arrows denote 












Plks and the Centrosomes 
The centrosome plays a major role in organizing the microtubule cytoskeleton of 
the cell and is the organizational centre of an astral array of microtubules that participate 
in cellular functions including intracellular trafficking, cell motility, cell adhesion, and 
cell polarity. In proliferating cells, the centrosomes participate in the assembly and 
organization of the mitotic spindle, their spatial orientation, and cytokinesis (Azimzadeh 
and Bornens, 2007). 
The centrosome consists of two centrioles with an orthogonal arrangement linked 
together at their proximal regions by a matrix consisting of proteins of the pericentrin 
family (Nigg, 2007; Dawe et al., 2007). The centrosomes replicate once during the cell 
cycle with each centrosome consisting of a mother/daughter centriole. During Gi, 
centriolar disengagement occurs through the actions of separase (Tsou and Stearns, 
2006). Though the orthogonal arrangement is lost, the centrioles are still connected by a 
tether of microfilaments (Bahe et al., 2005). In S phase, a procentriole grows from the 
existing centriole at an orthogonal angle through the activity of several centriolar 
proteins. The procentriole continues to grow till G2 until it reaches full maturity. 
Subsequently, the tether of filaments connecting the two mother centrioles together is 
severed to allow the centrosomes to enable spindle formation and chromosome 
segregation during mitosis (Mayor et al., 2000). 
The centrosome has also been implicated in playing a role in DNA damage 
checkpoint control (Fletcher and Muschel, 2006). Centrosome inactivation has been 
observed to be part of the DNA damage control system seen in Drosophila. In response 
to DNA damage, centrosome function was abrogated causing spindle defects and 
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subsequent failure in chromosomal segregation. These results indicated that centrosome 
inactivation is a checkpoint independent and mitosis-specific response to genotoxic 
stresses (Sibon et ah, 2000). Additionally, in mammalian cell lines, centrosomal 
segregation is inhibited in G2 in response to DNA damage. Centrosomal segregation is 
controlled by the protein kinase Nek2 whose activity is inhibited by DNA damage 
(Fletcher et al., 2004). Interestingly, Plkl can interact with and phosphorylate Nek2 
promoting centrosomal segregation. However, in response to DNA damage the activity of 
Plkl is inhibited, therefore preventing Nek2 from promoting centrosomal segregation. 
The inhibition of centrosome segregation occurs in an ATM/ATR dependent manner 
(Zhang et al, 2005). 
Members of the Plk family have been implicated to play additional crucial roles in 
the centrosome cycle. In fission yeast, loss of function of Plkl homologue, Plol leads to 
mitotic arrest where the chromosomes are condensed with only a monopolar spindle 
present (Ohkura et ah, 1995). In contrast, in budding yeast, Cdc5 may be required for 
microtubule nucleation, though Cdc5 activity is not essential for the establishment of 
bipolar spindles (Lee et ah, 2005). In Drosophila, Plk homologue polo is required for the 
recruitment of two crucial centrosomal components: CP190 and y-tubulin. In polo 
mutants, CP190 and y-tubulin are unable to localize specifically to the centrosomes, 
instead they scatter throughout the mitotic spindles (Dai and Cogswell, 2003). A similar 
inability to recruit y-tubulin to the centrosomes has also been observed in mammalian cell 
lines (Lane and Nigg, 1996). In addition, polo is required to phosphorylate and activate 
centrosomal protein Asp which is required for microtubule nucleation (Avides et al., 
2001). Asp mutants present mitotic spindles with highly unfocused poles and a high 
16 
mitotic index. In polo mutants, Asp is still able to localize to the centrosomes, though its 
activity is negligible. In polo and asp double mutants, there is a substantial increase in 
mitotic index (Gonzalez et al., 1998). Polo is also required for the nucleation of 
microtubules by centrosomes. The chaperone protein heat shock protein 90 (Hsp90) is 
required to ensure the stability of polo. Inhibition of Hsp90 results in inactivation of polo 
kinase activity, thereby abolishing the nucleation of the microtubules (de Career et ah, 
2001). In Xenopus it is also assumed that Plxl regulates centrosome separation and 
maturation by recruiting proteins to the centrosomes. This assumption is supported by the 
finding that inhibition of Plxl results in monopolar spindles with a-tubulin not localizing 
to the centrosomes (Qian et al., 1998). 
In mammalian cells, centrosome maturation is also dependent on Plkl, which 
phosphorylates Nip, a centrosome protein. This allows Nip to be removed from the 
centrosomes and for the recruitment of microtubule nucleation scaffolding (Casenghi et 
al., 2003). In addition, Plkl plays a role in centrosome separation as depletion of Plkl 
leads to monopolar spindles and eventually mitotic arrest (Lane and Nigg, 1996). Plkl 
may also regulate spindle formation as it has been shown to phosphorylate a-, P-, y-
tubulins and the tubulin stabilizing protein TCTP (Feng et al, 1999) (Yarm, 2002). 
Interestingly, it has been shown that Plkl does not need to be bound to the centrosomes 
to perform its centrosomal functions. Hanisch et al., 2006 showed that delocalized Plkl 
can still contribute to centrosome maturation, separation and spindle formation but not 
chromosome segregation. 
Plk2 kinase activity is required for initiation of centriole duplication at the Gi/S 
transition. Previous work has shown that overexpression of a catalytically inactive form 
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of Plk2 blocks centriole duplication (Warnke et al, 2004). Subsequently, inhibition of 
Plk2 through siRNA also blocked centriole duplication. Alternatively, overexpression of 
Plk2 causes an increase in centrosome number. Plkl has also been described to be 
required for centriole duplication (Liu and Erikson, 2002). Though in contrast to Plk2, 
kinase activity of Plkl is not required for initition of centriole duplication at the Gi/S 
transition (Warnke et al., 2004). Whereas Plk2 initiates centrosome duplication, Plkl 
ensures centrosome maturation (van de Weerdt and Medema, 2006). To date, no evidence 
has been presented implicating Plk3 with a role in centriole duplication or centrosome 
function. 
Plks and Oncogenesis and Tumor Development 
Since Plks are crucial cell cycle regulators, aberrant regulation of their function 
may contribute to oncogenesis, designed as a shift to cellular proliferation stimulating 
signals to encourage uncontrollable cellular growth. This uncontrolled cell growth will 
eventually lead to tumor formation and cancer (Eckerdt et al., 2005). Plkl expression 
and activity are tightly controlled throughout the cell cycle, though Plkl mRNA and 
protein levels have been found to be significantly increased in proliferating cells (Wolf et 
al., 2000). Plkl is over expressed in tumor cell lines, indicating that Plkl could lead to 
enhanced cellular proliferation and eventually cell transformation (Simizu and Osada, 
2000). Elevated Plkl levels are also found in a number of cancers including non-small-
cell lung cancer, head/neck squamous cell carcinomas, esophageal carcinoma, 
oropharyngeal carcinomas, melanomas, breast cancer, ovarian cancer, pancreatic cancer, 
prostate carcinomas and papillary carcinomas (Eckerdt et al., 2005). Increased levels of 
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Plkl have also been correlated with severity of diagnosis and patient prognosis (Kneisel 
et al, 2002). 
The ability of Plkl to induce oncogenesis may be due to its capacity to interact 
with several tumor suppressor genes. Plkl is able to to bind to the DNA binding domain 
of p53 (Ando et al., 2004) and phosphorylate a residue which blocks p53's transcriptional 
activity inhibiting its proapoptotic function (Xie et al., 2001). In contrast, p53 activity is 
significantly stabilized in Plkl-depleted cells (Liu and Erikson, 2003). 
Checkpoint kinase 2 (Chk2), another tumor suppressor protein also interacts with 
Plkl. A Chk2 mutant lacking catalytic activity has been shown to contribute to increased 
risk of breast cancer (Meijers-Heijboer et al., 2002). Chk2 and Plkl both colocalize at the 
centrosomes in early mitosis, and to the mid-body in late mitosis (Tsvetkov et ah, 2003). 
In response to ionizing radiation, Plkl can phosphorylate Chk2 at Thr-68, a site normally 
phosphorylated by ATM. The phosphorylation of Chk2 by ATM usually activates Chk2 
which then phosphorylates BRCA1 which inhibits the activity of Plkl (Ree et al., 2003). 
Though the physiological significance of Plkl's phosphorylation of Chk2 remains to be 
elucidated, it is believed the Plkl phosphorylation of Chk2 may contribute to a crosstalk 
between the DNA damage pathways and mitotic regulation (Matsuoka et ah, 2000). 
A network of tumor suppressor proteins is in place to suppress the oncogenic functions of 
Plkl, inhibiting its ability to promote mitosis and cell growth. Therefore, in response to 
DNA damage, it requires the loss of function of numerous tumor suppressor proteins to 
promote oncogenesis. It is believed that Plkl function is inhibited in two ways in 
response to DNA damage. If damage occurs within interphase, Plkl activity is inhibited 
in an ATM/ATR dependent manner through the activity of either Chkl or BRCA1. In 
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response to DNA damage occurring within mitosis, Plkl is inhibited through an 
ATM/ATR independent manner, through the activation of retinoblastoma protein (RB) 
by p53 (Eckerdt et al, 2005) (Figure 3). 
While Plk2 expression has yet to be correlated with the progression or 
suppression of tumor formation in any cancer, through its actions in the cell cycle, Plk2 
may play a crucial tumor suppressor role. In response to DNA damage, the activity of 
Plk2 is transcriptionally up-regulated in a p53 dependent manner. This activation is able 
to prevent mitotic catastrophe following mitotic spindle damage by activating the spindle 
checkpoint (Burns et al., 2003). The activation of the spindle checkpoint prevents the 
completion of mitosis which can contribute to genomic instability and the promotion of 
oncogenesis. 
In contrast to Plkl, Plk3 expression is negatively correlated with the development 
of cancer. Plk3 mRNA levels are either undetectable or down-regulated in lung 
carcinomas (Li et al., 1996), head/neck squamous cell carcinomas (Dai et al., 2000), and 
in carcinogen-induced rat colon tumors (Dai et al., 2002). Furthermore, ectopic 
expression of Plk3 decreases cellular proliferation in fibroblasts (Dai et al., 2000), while 
over expression of a catalytically active form of Plk3 induces chromatin condensation, 
rapid cell cycle arrest and eventual apoptosis (Conn et al., 2000; Wang et al., 2002). 
These observations indicate a tumor suppressor role for Plk3 though, to the contrary, Plk3 
along with Plkl were both found to be over expressed in malignant epithelial ovarian 
tumors, with over-expression correlating with an enhanced mitotic index and decreased 
patient survival (Weichert et al, 2004). 
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In contrast to Plkl during the cell cycle, which mediates oncogenic cellular 
transformation, Plk3 inhibits mitosis in the presence of damage to the genome. Plk3 
activation in response to DNA damage is mediated in an ATM-dependent fashion. Plk3 
can in turn activate tumor suppressor proteins like Chk2, which subsequently inhibit the 
mi to tic-promoting functions of Plkl, or p53 which initiates apoptotic pathways (Xie et 
al, 2001). Therefore, Plk3 function maybe crucial to inhibiting the progression of cells to 
an oncogenic state. 
Polo-like Kinase 4 (Plk4)/Sak 
Plk4 or Sak (Snk/Plk-akin kinase), was first identified in a screen of a murine 
lymphoid cDNA library for wheat germ agglutinin (WGA) resistant clones and was 
found to be a putative protein-serine/threonine kinase. Due to its expression pattern and 
sequence similarity with Drosophila polo, it was suggested that Plk4 played a role in cell 
cycle regulation (Fode et al, 1994). Murine Plk4 is located on chromosome 3 while the 
human homologue is found on chromosome 4q28 (Swallow et al., 2005). In mice, two 
isoforms have been identified while only a single isoform of the product protein found in 
humans. The Plk4-a and Plk4-b variants differ in respect to the C-terminus end. Plk4-a 
encodes a 925 amino acid (aa) protein while Plk4-b encodes a 464 aa protein. The first 
416 aa of Plk4-a and Plk4-b are identical while at the C-terminus end Plk-a region 
encodes 509 aa and Plk-b encodes 48 aa. Murine Plk4 has 15 coding exons and both the 
Plk-a and Plk-b variant are encoded for by a single gene. Human Plk4 differs from the 
murine Plk4-a in that contains a 34 aa insertion adjacent to exon 5 that is found in the 
murine Plk4-b variant (Hudson et al., 2000). 
21 
Figure 3: Interactions between Plks and Tumor Suppressor Proteins 
Members of the Plk family interact with tumor suppressor proteins and have been 
implicated in the progression or inhibition of oncogenesis. Plkl activity is either inhibited 
directly or indirectly by ataxia telangiectesia and Rad3 related (ATR), ataxia 
telangiectesia mutated (ATM), checkpoint kinase 1 (Chkl), checkpoint kinase 2 (Chk2), 
Breast cancer 1 gene (BRCA1), Retinoblastoma protein (pRb) and p53. The inhibition of 
Plkl activity is in response to activation of the DNA damage or mitotic spindle 
checkpoints. Whereas Plkl promotes progression through the cell cycle, Plk2 and Plk3 
suppress the cell cycle in response to damage. Loss of function of one or more of these 
tumor suppressor proteins, can lead to aberrant regulation of the cell cycle and the 
progression of oncogenesis. Though the exact function of Plk4 as a tumor suppressor or 
oncogene has yet to be determined, the fact that heterozygous Plk4 mice develop tumors 
at a rate higher than wild type litters, supporting the notion that Plk4 plays a significant 













Plk4 Expression Profile and Localization 
Like Plkl, Plk4 mRNA and protein levels are regulated in a cell cycle dependent 
manner with Plk4 expression low in Gl, increasing during DNA replication and G2 and 
peaking during cytokinesis. Plk4 is targeted for ubiquitination by the anaphase promoting 
complex (Fode et al., 1996). Plk4 expression is also highest in rapidly proliferating 
tissues, such as the testis, spleen, and thymus (Fode et ah, 1994). Differing views have 
emerged concerning the localization of Plk4 during the cell cycle. Previous work has 
shown that Plk4 localized to the nucleolus and perinuclearly in G2, and to the 
centrosomes in early mitosis. During anaphase, Plk4 localized throughout the cell and in 
telophase to the cleavage furrow (Hudson et al, 2001). This pattern of localization was 
supported by (Martindill et al, 2007) where Plk4 showed a similar localization pattern 
and was shown to phosphorylate the developmental protein Handl, controlling its 
nucleolar release. In contrast, Habedanck et al, 2005 showed Plk4 localized exclusively 
to the centrosomes throughout the cell cycle. In support of this finding, Bettencourt-Dias 
et al, 2005 working with Drosophila melangastor cells showed Plk4 localization to the 
centrosomes throughout the cell cycle. Among the other Plk family members, both of the 
polo box domains are necessary for subcellular localization (Jang et al., 2002), but in 
Plk4 there is debate whether the polo box domain itself is sufficient for localization. 
Previous work has shown that the polo box itself is sufficient for localization of Plk4, 
though a truncated mutant lacking both the polo box and cryptic polo box region reduced 
the efficiency of Plk4 for localization (Leung et al., 2002). In contrast, an additional 
study has shown that the polo box region itself is not sufficient for localization 
(Habedanck et al, 2005). 
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Plk4 and the Centrosomes 
Plk4 has been identified as a key regulator of centriole duplication. Over-
expression of Plk4 leads to centrosome amplification through the generation of numerous 
progeny centrioles from a parental centriole (Habedanck et ah, 2005; Kleylein-Sohn et 
al., 2007). Conversely, inhibition of Plk4 activity leads to inhibition of centriole 
formation in Drosophila cells and subsequently the formation of basal bodies and flagella 
(Habedanck et al., 2005; Bettencourt-Dias et al., 2005). In the initial studies, both kinase 
activity and presence of the cryptic polo box domain of Plk4, which is necessary for 
localization to the centrosome were required to induce amplification. The necessity of the 
kinase domain indicates that Plk4 may be required to target key substrates that are 
involved in the centrosome cycle. It was also observed that over expression of a 
catalytically inactive form of Plk4 could induce some centrosome amplification, albeit 
through a different mechanism that likely involves cell division failure through a 
dominant-negative method of action (Habedanck et al., 2005). Over expression of Plk4 
produces a phenotype reminiscent of a flower, with progeny centrioles arranged around 
the parental centriole like petals. Plk4 appears to localize to the parental centriole at the 
Gi/S transition, and this localization initiates multiple centriole duplication sites around 
the parental centriole. In addition, the localization of Plk4 to the parental centriole 
initiates that rapid recruitment of centriole proteins hSas6, CPAP, Cepl35 and y-tubulin 
to the parental centriole (Kleylein-Sohn et al., 2007). Whether Plk4 interacts with or 
phosporylates any of these proteins to recruit them to the parental centriole remains to be 
elucidated. These proteins along with CP110 provide the foundation for procentriole 
formation. Plk4 appears to be the upstream regulator required for initiation of centriole 
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duplication and the recruitment of other proteins. Inhibition of hSas-6, CPAP, Cepl35, 
CP110 or y-tubulin via siRNA suppresses Plk4's ability to induce centriole formation 
(Kleylein-Sohn et ah, 2007). Therefore, the activity of Plk4 is likely tightly regulated 
within the cell cycle since aberrant activity would produce centriole over duplication. The 
kinase responsible for activating Plk4 function or the counteracting phosphatase 
responsible for suppressing Plk4 activity remains to be identified. 
It is noted that cyclin-dependent kinase 2 (Cdk2) has been implicated as having a 
role in centrosome duplication and that inhibition of Cdk2 activity suppresses centrosome 
duplication (Matsumoto et ah, 1999). Interestingly, over-expression of Plk4 requires the 
activity of Cdk2 to produce centrosome amplification, while a catalytically inactive 
Cdk2, or the presence of the Cdk2 inhibitor p27 suppresses Plk4-induced centrosome 
amplification. Conversely, Cdk2 requires Plk4 activity to perform its role in centrosome 
duplication, indicating Cdk2 and Plk4 in their respective functions cooperate 
(Habendanck et ah, 2005). 
Interestingly, the over-expression phenotype of Plk4 is similar to the phenotype observed 
in heterozygous Plk4 MEFs. The heterozygous MEFs present a phenotype of increased 
centrosomal amplification, multipolar spindle formation and subsequent mitotic failure 
(Ko et ah, 2005). It is plausible that reduced Plk4 activity in the heterozygous MEFs can 
cause cellular division failure from aberrant centrosome segregation or abnormal mitotic 
spindle formation (Habendanck et ah, 2005). The findings within heterozygous MEFs are 
likely due a reduced gene dose of Plk4. 
In contrast, depletion of Plk4 in human cells by siRNA causes a step by step 
reduction in centriole number resulting in the presence of monopolar spindles during 
26 
mitosis (Habedanck et al, 2005). Additionally, inhibition of Plk4 via siRNA leads to an 
increased mitotic index and an increase in apoptotic cells (Bettencourt-Dias et al., 2005). 
In Drosophila cells, inhibition of Plk4 leads to the failure of several centrosomal proteins, 
y-tubulin, CP190 and Cnn to localize to the centrosomes. Additionally, cells lacking y-
tubulin at the spindle poles also had no detectable pericentrin-like protein (D-PLP). In 
contrast, inhibition of polo did not affect D-PLP presence at the spindle poles. Although 
inhibition of Plk4 leads to a reduction and failure in centrosome number and centriole 
formation, in contrast inhibition of polo doesn't reduce centrosome number or affect 
centriole formation. Interestingly, inhibition of Plk4 and a reduction in centrosome 
number did not effect cell cycle progression. However, Plk4 null Drosophila adults were 
uncoordinated and eventually died as a result of a failure to produce basal bodies, a 
centriolar derived structure in the sensory neurons (Bettencourt-Dias et al., 2005). 
Plk4 Role in Mitosis 
Plk4 plays a crucial role in regulating centrosome dynamics, although whether 
Plk4 plays any additional roles in the cell cycle remains to be elucidated. Experimental 
evidence suggests a role for Plk4 in promoting mitotic entry since Plk4 interacts with two 
key genes in the G2/M transition. Plk4 interacts with and phosphorylates Cdc25C (Bonni 
et al, 2008) and interacts with cyclin B (Hudson et ah, unpublished data), though the 
functional significance of these interactions remains to be described. Plk4 may also play a 
role in promoting mitotic exit. In Plk4 null mice where embryonic lethality is observed, 
high levels of cyclin B are observed in anaphase and telophase cells (Hudson et al, 
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2001). This is indicative of cells arresting late in mitosis. Therefore, Plk4 may play a 
crucial role in the APC/C dependent destruction of cyclin B. 
Plk4 Role in DNA Damage Pathways 
As with the other Plk family members, Plk4 may also play a role in the DNA 
damage pathways since Plk4 has been shown to interact with p53 (Swallow et al., 2005) 
and Plk4 expression is repressed in a p53 dependent manner in response to DNA 
damaging agents (Li et al., 2005). It was determined that p53 repression of Plk4 activity 
occurred through the recruitment of a histone deacetylase (HDAC) transcription 
repressor. In addition, Plk4 repression through RNA interference allowed p53-induced 
apoptosis to occur, while Plk4 overexpression attenuated p53-mediated apoptosis. 
Though a direct role for Plk4 in DNA damage pathways has yet to be described, Plk4 has 
been shown to interact with various sensor, transducer and effector proteins including 
ATM, ATR, Chkl, Chk2, and members of the Cdc25 phosphatase family (Hudson et al., 
unpublished data). Therefore, it is plausible that Plk4 may play a substantive role in the 
cellular response to genotoxic stresses. 
Plk4 Null Mice 
To study the role of Plk4 in embryogenesis and to determine the effect of loss of 
Plk4 function in mice, a Plk4 null allele was generated by replacing exons 1 and 2 with a 
Neo gene deleting the start of translation (Hudson et al., 2001). It was discovered that 
Plk4 null mice arrested at approximately 7.5 days post coitum after gastrulation had 
occurred. Formation of the neural plate was evident but somite development and neural 
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tube formation failed to occur (Hudson et a/., 2001; Swallow et al, 2005). An 
examination at 8.5 days found that Plk4 null embryos were smaller than both wild type 
and heterozygous embryos with the embryonic and extra embryonic structures that were 
reduced in size. Null embryos showed an increased number of cells present in mitosis 
indicating a block or delay in mitosis which was confirmed by phosphorylated histone H3 
detected six times more frequent in null embryos. Outgrowths from E2.5 blastocysts were 
compared, and Plk4 null outgrowths were smaller and DNA synthesis was reduced in 
comparison to the wild type. As seen with embryos at E8.5, 68% of Plk4 null outgrowths 
were positive for phosphorylated histone H3 compared to only 17% of wild type 
outgrowths indicating an anaphase block had occurred in the nulls (Hudson et al., 2001). 
Plk4 null blastocysts also displayed an increased number of cells present with a dumbbell 
morphology indicating a block in telophase (Hudson et al., 2001; Swallow et al., 2005). 
Plk4 null embryos also presented a high number of cells with a late mitotic delay leading 
to a high apoptotic rate. 
Plk4 was the first member of the polo like kinase family to be studied by germline 
mutation; whereas experimental data indicates that Plk4 is required for embryonic 
development, a study by Ma et al., 2003 showed that in contrast Plk2 null mice were not 
embryonic lethal. Plk2 null mice were smaller than their littermates and show a slight 
delay in skeletal development. In addition, Plk2 null mice were all fertile and show 
comparable survival rates to their heterozygous and wild type littermates (Ma et al., 
2003). These results indicated that although Plk2 may play an essential role in cell cycle 
progression, it is not essential for embryonic development. To date, no germline 
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mutations of Plkl or Plk3 have been devised to assess the functional significance of these 
genes in an animal system. 
Plk4 Mouse Embryonic Fibroblasts (MEFs) 
Consistent with the embryonic lethality observed with Plk4 null embryos, the 
establishment of Plk4 null MEFs was unsuccessful indicating the Plk4 is not only 
necessary for embryonic development but also for cell viability (Hudson et al 2001; Ko et 
al., 2005). In contrast, Plk2 null MEFs are viable though they are delayed in entering S 
phase (Ma et al, 2003). 
Plk4 heterozygous MEFs are viable though they exhibit a slower growth rate 
compared to wild type MEFs (Ko et al., 2005). Plk4 heterozygous MEFs presented a 
number of mitotic defects including abnormal spindle number as well as abnormal 
chromosomal number and segregation. The percentage of MEFs with greater than three 
centrosomes was significantly increased in heterozygous Plk4 MEFs, while the presence 
of more than one microtubule organizing centres (MTOC) was observed in 
approximately one-third of Plk4 heterozygous MEFs in interphase (Ko et al., 2005; 
Swallow et al., 2005). A similar phenotype is observed in MEFs deficient in p53 or p21 
with an incidence of centrosome amplification similar to that of Plk4 heterozygous MEFs 
(Carroll et al., 1999). Tatapore et al. showed that in p53 null MEFs there was an increase 
in centrosome and MTOC number. Plk4 heterozygous MEFs contain mRNA and protein 
levels at about 50% the level found in wild type MEFs (Swallow et al, 2005). 
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Cancer Development in Plk4 Heterozygous Mice 
Plk4 heterozygous mice are healthy and fertile and show no abnormal defects 
early in development (Hudson et ah, 2001; Ko et ah, 2005). On the other hand, aged Plk4 
heterozygous mice (18-24 months) developed primary hepatocellular (HCC) liver tumors 
at a frequency of 50% in comparison with only 3% in wild type mice. These liver tumors 
were typically multifocal indicating a predisposition to tumor development throughout 
the liver. Further examination showed that the hepatocytes presented a high mitotic index 
and nuclear atypia. Tumor development in heterozygous mice was also observed in the 
lung with papillary adenocarcinomas discovered in the periphery of the lung parenchyma. 
In addition, a few heterozygous mice developed large soft tissue tumors of the axilla and 
upper chest wall (Ko et al., 2005). 
A two-thirds partial hepatectomy was employed to study the molecular basis why 
Plk4 heterozygous mice were predisposed to mitotic errors. This method was employed 
to induce dormant hepatocytes back into the cell cycle. It was shown that 44 hours after 
partial hepatectomy, Plk4 heterozygous hepatocytes had a significantly higher incidence 
of tri- or tetrapolar spindles leading to abnormal mitosis. Introduction of hepatocytes in S 
phase was delayed by four hours in heterozygotes as seem by the persistence of Cdk2 
activity and the delay of phosphorylation of Rb. Subsequently, entry into mitosis was 
delayed in heterozygous Plk4 livers as observed by the persistence of cyclin Bl, and 
phosphorylated Cdkl. Seven days post hepatectomy, heterozygous hepatocytes were 
poorly organized, though normal liver mass was restored and no difference in the survival 
rate was observed in both wild type and heterozygotes,. Six months post partial 
hepatectomy, 70% of heterozygous mice displayed hepatocellular dysplasia with nuclear 
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atypia as well as disorganization in the normal liver architecture, while wild type livers 
were normal. Twelve months post partial hepatectomy, all heterozygous Plk4 mice 
presented abnormal liver histology with 37% developing HCC tumors that were 
multifocal in nature with a high degree of aberrant mitotic errors. The majority of the 
wild type Plk4 mice had normal liver architecture. These studies reasoned that some 
hepatocytes in heterozygote livers with abnormal spindle morphology escaped 
programmed cell death and passed this phenotype to subsequent generations of 
hepatocytes leading to the increased development of liver tumors in the Plk4 mice (Ko et 
al, 2005). 
The results observed in heterozygous mice are consistent with the observation that 
the Plk4 gene is present on human chromosome 4q28, a syntenic region that frequently 
undergoes rearrangement in hepatocellular carcinomas. It was determined that the 
increased incidence of hepatomas in Plk4 heterozygous mice resulted from 
haploinsufficiency and that the Plk4 gene dosage is crucial for suppression of 
carcinogenesis (Ko et al,2005). 
PIk4 Role in Oncogenesis 
In contrast to heterozygous Plk4 mice where a reduced gene dose of Plk4 was 
correlated with tumor development, Plk4 was found to be over expressed in colorectal 
cancers. Similar over expression in colorectal cancers is observed with Plkl. Expression 
of both Plkl and Plk4 increased with the age of the patient, and interestingly, the 
expression profiles of Plkl and Plk4 correlated with each other (Macmillan et al, 2001). 
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Few interacting partners of Plk4 have been identified therefore it has been 
difficult to determine the function that Plk4 may play in the progression or suppression of 
oncogenesis. Like Plkl, Plk4 expression is transcriptionally repressed by a p53 mediated 
pathway (Li et al., 2005). Although the characterization of this repression has yet to be 
characterized in response to DNA damage, it provides evidence that the functions of Plk4 
may impact upon oncogenic properties. In contrast, heterozygous Plk4 MEFs display a 
phenotype typified by multiple centrosomes, multipolar spindles and mitotic failure (Ko 
et al., 2005). This phenotype was similar to that observed following over expression of a 
catalytically inactive Plk4 mutant. The results suggest that reduced Plk4 activity can 
cause occasional cellular division failure as a result of aberrant centrosome duplication 
and subsequent mitotic spindle malformation. This cell division failure can lead to either 
aneuploidy or polyploidy, which could in turn contribute to the incidence of tumors in 
heterozygous mice (Habendanck et al., 2005). 
Experimental Approach 
The use of microarrays is an established technique in the field of molecular 
biology which allows for the large-scale examining of the expression profiles of 
thousands of genes within a genome. Microarrays allow for the characterization of global 
expression patterns between a reference and one or multiple experimental conditions. The 
advent of microarray technology has provided researchers with an invaluable tool to 
elucidate the function of genes in cellular processes. For the purpose of my 
experimentation, microarray technology was employed to examine cellular variations of 
transcript levels based of Plk4 gene dosage in mouse embryonic fibroblasts. 
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Microarray employs the principle that a given cDNA molecule will bind to its 
complement on a DNA template from which it has originated (Southern et al., 1999). 
Two types of microarrays technologies are being employed: oligonucleotides and spotted 
cDNA arrays. Oligonucleotides are short synthetic sequences of DNA often between 
twenty to sixty base pairs in length which are representative of a single gene or a family 
of gene splice variants (Lipshutz et al., 1999). Spotted arrays or complementary DNA 
(cDNA) arrays contain expressed sequence tags (ESTs) which are small pieces of a DNA 
sequence generally between 200 to 500 nucleotides long in length that are generated by 
sequencing either one or both ends of an expressed gene (Duggan et al., 1999). Oligo 
arrays differ from spotted arrays in the way they are manufactured. Oligonucleotide 
arrays are produced by printing short oligonucleotide sequences directly onto the array 
surface. Oligo arrays can be synthesized by photolithographic synthesis, where light and 
light-sensitive masking agents are used to build one nucleotide sequence at a time across 
an array surface. Spotted arrays probes are synthesized prior to deposition on the array 
surface and are then "spotted" onto glass. Spotted arrays are usually synthesized by 
means of a robotic arm, which contains an array of pins or needles which deposits DNA 
probes on the designated location on the array surface. For the purpose of the present 
study, cDNA microarrays were employed. 
Spotted arrays are scanned via a microarray scanner at two wavelengths to 
produce images for data analysis: 532nm which causes excitation of the Cy3 fluor which 
emits a wavelength of 570nm in the green part of the visual spectrum and 635nm which 
causes the excitation of Cy5 which emits a wavelength of 670nm in the red part of the 
visual spectrum. Differences in gene expression between the reference and experimental 
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states are measured based on the visual intensities emitted by the Cy3 and Cy5 dyes 
which represent the amount of mRNA transcript per a specific gene that hybridized to the 
array. A visual representation of yellow represents equal hybridization of a gene for both 
the reference and experimental cDNA and therefore equal mRNA expression. While a 
predominantly red visualization represent that for a gene in the experimental condition, 
there were more mRNA transcripts present and therefore it was upregulated. A 
predominantly green visualization represents that the gene in the reference condition 
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Figure 4: Composite View of Cy3 and Cy5 Labeled Microarray 
The wild type Cy3 labeled cDNA is scanned at 532nm causing the Cy3 fluor to emit at 
570nm, while the heterozygous Cy5 cDNA is scanned at 635nm causing an emission at 
670nm. A composite image is produced by the Scanarray software using the Cy3 and 
Cy5 scanned images. A predominately green spot indicates increased transcript 
expression in wild type Plk4 MEFs, while a predominately red spot indicates increased 
transcript expression in heterozygous Plk4 MEFs. A yellow spot indicates equal 
transcript expression between wild type and heterozygous Plk4 MEFs. 
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Chapter 2 
Objectives of the Study 
Significant phenotypic differences are observed between wild type and 
heterozygous Plk4 mice and mouse embryonic fibroblasts (MEFs), although the exact 
mechanisms by which these phenotypic differences occurs has yet to be fully elucidated. 
The aim of this study was firstly, to provide a general survey of differences in the 
transcript profile between wild type and heterozygous MEFs using microarray 
technology. Secondly, Plkl, Plk2, and Plk3 have been implicated to play substantive 
roles in the cell cycle response to DNA damage. Hence, it is plausible that Plk4 also plays 
a significant role in the DNA damage pathways. Therefore, transcriptional and protein 
difference were examined in wild type and heterozygous MEFs in response to both 
ionizing and ultraviolet radiation. 
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Chapter 3 
Materials and Methods 
Establishment of Primary Mouse Embryonic Fibroblasts (MEFs) 
Mouse embryonic fibroblast cell lines were established by sacrificing a pregnant 
female mouse 12.5 days post coitum by carbon dioxide (CO2) asphyxiation. The uterine 
horns were removed and washed with 70% ethanol. Each embryo was separated from the 
placenta and placed in 1ml of Hanks Balanced Salt Solution (HBSS) (Sigma). The 
embryos were minced with a razor blade until they were pipettable. The resulting 
cell/tissue solution was suspended in 1ml 10X Trypsin (Sigma) and placed in an 
incubator at 37°C with 5% C02 for 15 minutes. 10ml of MEF media (Dulbecco's 
Modified Eagles Medium (DMEM; Sigma) containing 20% Fetal Bovine Serum (FBS; 
Sigma), 1% penicillin-streptomycin (Gibco) and 250 ug/ml gentamicin (Gibco)) were 
added to the MEF suspension and transferred to a 50 ml falcon tube. Tissue was allowed 
to settle to the bottom of the tube and the supernatant was transferred to a 15 ml falcon 
tube and subjected to centrifugation at 100 x g for five minutes. The supernatant was 
removed and the resulting pellet was suspended in 10 ml of MEF media and plated on a 
10 cm tissue culture dish and placed in an incubator at 37°C with 5% CO2. 
When the MEFs reached confluency, they were washed once with HBSS, 
trypsinized with 1 ml 1 OX Trypsin (Sigma) for 5 min at room temperature, resuspended 
in fresh MEF media, pelleted by centrifugation at 100 x g for five minutes and split at a 
ratio of 1 to 10, with 200 ul kept for genotyping. MEFs were allowed to reach 80% 
confluency, and then were frozen down. Briefly, MEFs were washed once with HBSS, 
trypsinized with 1ml 10X Trypsin (Sigma) for 5 min at room temperature, resuspended in 
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fresh MEF media, pelleted by centrifugation at 100 x g for five minutes and resuspended 
in 1ml of cold MEF freezing media (MEF media containing 10% dimethyl sulfoxide 
(DMSO) (Sigma)). MEFs were kept at -80°C for 3 days and then transferred to liquid 
nitrogen for long term storage. 
MEF Genotyping 
Isolation of DNA from MEFs was performed by adding 620 ul Proteinase K 
buffer (50mM Tris, lOOmM EDTA, lOOmM NaCl, 1% SDS) and 30 ul of 20 mg/ml 
Proteinase K (Roche). The solution was placed in a 55°C water bath overnight. A 1:1 
ratio of water saturated phenol (Sigma) and chloroform (Sigma) was added and the 
solution was placed on a Nutator Mixer (Becton-Dickinson) for lhr. The solution was 
centrifuged in a table top microcentrifuge (Jouan) at 4000 x g for 10 min. The aqueous 
phase of the resulting mixture was transferred to an eppendorf tube containing 650 ul of 
isopropanol and centrifuged at 4000 x g to pellet the DNA. The DNA was washed with 
70% ethanol and resuspended in 100 ul of deionized water. 
PCR genotyping established whether the MEFs were Plk4 wild type or 
heterozygous. Primers F25 (5'-GCCCCCACTAAGACGAC-3') and VEC523 (5'-
AGCTGGGGCTCGACTAG-3') amplified a wild type band at 316bp while primers F25 
and PR436 (5'-TGCTAGTAAATAATCCGACAGG-3') amplified a mutant band at 
403bp (Hudson et al., 2001). 
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RNA Isolation 
RNA isolation was performed using the RNeasy Mini Kit (Qiagen). Briefly, MEF 
cells were grown asynchronously to a confluency of 80% and washed twice with HBSS 
(Sigma) before trypsinization with 10X Trypsin (Sigma). Cells were then pelleted at 100 
x g for 5 min in a 15ml falcon tube and washed twice with HBSS in the falcon tube and 
spun at 100 x g for 3 min. After the second HBSS wash, cells were lysed with the 
addition of 600 ul lysis buffer and the lysates were homogenized with a Qiashredder 
(Qiagen) spin column and spun in a microcentrifuge (Juoan) at 4000 x g for 2 mins. 75% 
ethanol was added to the homogenized lysate to precipitate the total RNA. The solution 
was placed in an RNeasy Mini Column where the RNA was bound to the column. The 
RNA was washed three times in the column to get rid of any contaminants and then 
eluted with Diethyl Pyrocarbonate (DEPC) water. A spectrophotometer reading at A260 
was performed to estimate the concentration of the RNA. To confirm the integrity and 
quality of the RNA, a sample was run on the 2100 Bioanalyzer (Agilent) using the RNA 
6000 Nano Assay Kit. The RNA was flash frozen in liquid nitrogen and placed in the 
-80°C freezer until ready for use. 
Microarray 
Three plates of either wild type or heterozygous MEFs were pooled for RNA 
isolation as described. RNA was sent to the University Health Network (UHN) 
Microarray Centre in Toronto were the microarray experiments were performed. The 
samples were labeled using the UHN's standard indirect labeling protocol. Briefly, 10 
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micrograms of total RNA sample was used and following reverse transcription to cDNA 
labeled with Cyanine dyes Cy3 and Cy5 (Amersham Bioscience). Wild type Plk4 cDNA 
was labeled with Cy3 while heterozygous Plk4 cDNA labeled with Cy5. The labeled 
samples were hybridized to a Mouse 22.4K microarray chip containing 22 400 features. 
Hybridization was performed on an Advalytix Slidebooster (Advalytix) using DIG easy 
hybridization solution. The arrays were scanned using an Agilent G2565BA scanner and 
quantified using ArrayVision v.8.0 (Imaging Research Inc.). 
Synthesis of Complementary DNA (cDNA) 
RNA isolation was performed by the method stated previously. The quality of the 
RNA was examined using the bioanalyzer with the RNA used for reverse transcription if 
the RNA integrity number was greater than 8.0. Reverse transcription (RT) was 
performed to convert the total RNA isolated from the MEFs into cDNA. Complementary 
DNA was synthesized using 5 ug of total RNA, lul 0.5ug/ul oligo (dT) 12-18 primer 
(Invitrogen), lul lOmM dNTPs (Invitrogen) to a value of 12ul with DEPC water. The 
mixture was incubated at 65°C for five minutes in a heating block and then placed on ice 
for 2 minute. 4ul of 5X First-Strand Reaction Mix (Invitrogen) and 2ul 0.1M 
dithiothreitol (DTT) of were added to the mixture and incubated in a heating block at 
42°C for 2 minutes. 1 ul of Superscript II Reverse Transcriptase was added and the 
reaction was incubated at 42°C for 50 minutes for first strand synthesis. The reaction was 
terminated by incubating the mixture in a heating block at 70° for 15 minutes. The cDNA 
was stored at -20°C until use. 
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Polymerase Chain Reaction (PCR) 
i) Plk4 
All forward and reverse primers for PCR were designed to span intron/exon 
boundaries to prevent amplification of contaminating genomic DNA in the cDNA 
mixture. The primers for Plk4 (5- AGGGAAGCTAGGCACTTCATG-3'; 5-
GGAAGACCACCTTTTGAC-3') yielded a PCR product of 310 bp. PCR was performed 
in a 20 ul reaction mixture containing 2 ul of cDNA template, 2.5 ul of 10X PCR buffer, 
4.625mM MgCk, .5mM of dNTPs, 1 ul each of forward and reverse primers and 2.5 U of 
Hot Star Taq DNA Polymerase (Qiagen). PCR was performed using a Tpersonal 
(Biometra) programmable thermal cycler as follows: denaturation at 95°C for 15 minutes, 
then 38 to 42 cycles of denaturation at 94°C for 30 seconds, annealing at 48°C for 30 
seconds and extension at 72°C for 60 seconds. Completed PCR reactions were cooled to 
4°C and aliquots resolved by electrophoresis on a 2% tris-acetate-EDTA (TAE) agarose 
gel at 85 V for 85 minutes and visualized by ethidium bromide staining. Gels were 
imaged using a Chemi Genius Bio Imaging System (Perkin Elmer) using the Gene Snap 
software. All PCR products were run and imaged using the same methodology and 
equipment. 
ii) Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) 
Oligonucleotide primers for GAPDH (5'-GCTGAGTATGTCGTGGAGTCT-3'; 
5'-CAGAGCTGAACGGGAAGCTC-3') yielded a product of 410 bp. PCR was 
performed in a 20 ul reaction mixture containing 1 ul of cDNA template, 2.5 ul of 10X 
PCR buffer, 4.625mM MgCk, .5mM of dNTPs, .5 ul each of forward and reverse primers 
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and 1 U of Hot Star Taq DNA Polymerase (Qiagen). PCR was performed using a 
programmable thermal cycler as follows: denaturation at 95°C for 15 minutes, then 28 to 
32 cycles of denaturation at 94°C for 30 seconds, annealing at 57°C for 40 seconds and 
extension at 72°C for 40 seconds. PCR reactions were cooled to 4°C and aliquots 
resolved on a 2% agarose gel. 
iii) Prohibitin 
The primers for prohibitin (5'-CGTATCTACACCAGCATTGGC-3'; 5'-
TGTGGTGGAAAAGGCTGAGC -3') yielded a product of 301 bp. PCR was performed 
in a 20 ul reaction mixture containing 2 ul of cDNA template, 2.5 ul of 10X PCR buffer, 
2.0mM MgC12, .5mM of dNTPs, .75 ul each of forward and reverse primers and 2.5U of 
Hot Star Taq DNA Polymersae (Qiagen). PCR was performed using a programmable 
thermal cycler as follows: denaturation at 95°C for 15 minutes, then 32 to 36 cycles of 
denaturation at 94°C for 30 seconds, annealing at 55°C for 30 seconds and extension at 
72° for 30 seconds. PCR reactions were cooled to 4°C and aliquots resolved on a 2% 
agarose gel. 
iv) SAP30 Binding Protein (SAP30BP) 
The primers for SAP30BP (5'-CCAGAAGCTCTACGAGCGGAA-3'; 5'-
TGGTCTGAAGACTCCTACTATGAG-3') yielded a product of 190 bp. PCR was 
performed in a 20 ul reaction mixture containing 2 ul of cDNA template, 2.5 ul of 10X 
PCR buffer, 2.75mM MgCk, .5mM of dNTPs, 1 ul each of forward and reverse primers 
and 2.5 U of Hot Star Taq DNA Polymerase (Qiagen). PCR was performed using a 
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programmable thermal cycler as follows: denaturation at 95°C for 15 minutes, then 38 to 
42 cycles of denaturation at 94°C for 30 seconds, annealing at 57°C for 30 seconds and 
extension at 72°C for 30 seconds. PCR reactions were cooled to 4°C and aliquots 
resolved on a 2% agarose gel.. 
v) WNT-Inducible Signaling Pathway Protein 1 (Wispl) 
The primers for Wispl (5'-GCCTAATCACAGATGGCTGTG-3'; 5'-
CAATAGGAGTGTGTGCACAGGTG-3') yielded a product of 150 bp. PCR was 
performed in a 20 ul reaction mixture containing 2 ul of cDNA template, 2.5 ul of 10X 
PCR buffer, 1.5mM MgC^, .5mM of dNTPs, lul each of forward and reverse primers 
and 2.5U of Hot Star Taq DNA Polymerase (Qiagen). PCR was performed using a 
programmable thermal cycler as follows: denaturation at 95°C for 15 minutes, then 36 to 
40 cycles of denaturation at 94°C for 60 seconds, annealing at 54°C for 60 seconds and 
extension at 72°C for 60 seconds. PCR reactions were cooled to 4°C and aliquots 
resolved on a 2% agarose gel. 
Densitometry 
Densitometry was performed using the Gene Tools software from Perkin Elmer. 
Briefly, the program identified the correct gel lanes associated with the samples run using 
an algorithm. Subsequently, any unwanted lanes were deleted. Next, using a 
predetermined algorithm, the computer identified bands on the gel and was allowed to 
assign intensity values for the bands to eliminate any bias. Unwanted bands not necessary 
for analysis were removed. 
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TdT-Mediated dUTP Nick-End Labeling (TUNEL) Assay 
Wild type and heterozygous MEFs were plated on glass coverslips at 70% 
confluency in six well plates. MEFs were exposed to 40 mJ/cm2 ultraviolet radiation. 
MEF media was removed and the cells were washed twice with IX phosphate buffer 
saline (PBS). Cells were fixed in 4% paraformaldehyde in PBS at 4°C, Ohr, lhr, 2hr, 4hr, 
6hr, and 8hr post radiation. Cells were permeabilized in 0.2% Triton X-100 (Sigma) in 
PBS and washed twice in IX PBS. Cells were equilibrated in Equilibration buffer for 10 
minutes at room temperature. Equilibration buffer was removed and the cells were 
incubated with rTdT incubation buffer (88% equilibration buffer, 10% nucleotide mix, 
2% rTdT enzyme) for 60 minutes at 37°C in the dark to label apoptotic cells with 
fluorescien-12-dUTP. Cells were washed with 2X Sodium Salt Citrate (SCC) (20X SCC 
in deionized water) 15 minutes at room temperature to terminate the labeling reaction. 
Cells were washed three times with IX PBS at room temperature for 5 minutes. Cells 
were stained with 5ug/ml of propidium iodide (PI) in IX PBS to stain the nuclei of the 
cells. Subsequently, cells were washed three times with deionized water. Excess water 
was removed from the cover slips, one drop of Anti-Fade solution (Molecular Probes) 
was added and the cover slips were mounted on glass slides. Cells were viewed at high 
magnification at red fluorescence at 620 nm for propidium iodide and green fluorescence 
at 520 nm for fluorescien-12-dUTP. 200 cells per slide were counted to analyze the 
number of apoptotic cells and three trials were performed. DNase I was used as a positive 
control to induce DNA fragmentation indicative of apoptosis. 
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Exposure of MEFs to DNA Damaging Agents 
Wild type and heterozygous MEFs were exposed to ultraviolet light (UV) at 40 
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mJ/cm using a GS Gene Linker UV Chamber (Biorad) or ionizing radiation (IR) of 25 
Gy using a RX-650 Cabinet X-ray System (Faxitron) and RNA was isolated from the 
MEFs at desired time points. 
SDS-PAGE 
MEFs were exposed to either ultraviolet or ionizing radiation and then lysed 6 
hours post radiation. Cells were lysed with 1ml lysis buffer (50 mM Tris-Cl, 100 mM 
Nacl, 500 mM EDTA, 1% Triton-X) on ice for 20 min. Lysates were spun in a 
microcentrifuge at 4000 x g for 20 min at 4°C to remove cellular debris. A Bradford 
assay was performed to find out protein concentration. 2X loading dye containing 5% 0-
mercaptoethanol was added to 30 ug of lysates, and the samples were boiled for 5 min. 
The lystates were loaded onto either an 8% or 15% protein gel and subjected to SDS-
PAGE for 48 minutes at 200V. 
Western Blot Analysis 
After SDS-PAGE, the proteins were transferred onto a PVDF membrane 
(Millipore) using a semi-dry transfer apparatus (Biorad) at 12V for 45 minutes. The 
membrane was then blocked with Tris-buffer saline and Tween (TBST) buffer with 1% 
blotto to block non-specific protein binding for lhour at room temperature with gentle 
agitation. The membrane was washed three times with TBST for 5 minutes at room 
temperature. The membrane was then incubated with the desired primary antibody 
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(Appendix A) in TBST with 1% blotto for 1 hour at room temperature; then washed three 
times with TBST for 5 minutes. The membrane was incubated with the appropriate 
horseradish peroxidase secondary antibody (Appendix A) in TBST with 1% blotto for 45 
minutes at room temperature; then again washed three times with TBST for 5 minutes. 1 
ml of Supersignal West Femto Maximun Sensitivity Substrate (Pierce) was added to the 
membrane and the reaction between the horseradish peroxidase and its substrate was 
allowed to occur for 5 minutes. The proteins were then visualized by chemiluminescence. 
Stripping of Western Blots for Re-probing 
Stripping of Western blots was used to remove any bound primary and secondary 
from the blot so that other primary antibodies could be tested. Stripping buffer (100 mM 
P-mercaptoethanol, 2% SDS, 62.5 mM Tris-Cl at pH 6.7) was prewarmed to 50°C and 
added to the blot for 25 minutes at 50°C with gentle agitation. The stripping buffer was 
removed and the blot was incubated with prewarmed TBST for 25 minutes at 50°C. The 




Comparison between Transcript Profiles in Wild Type and Heterozygous Plk4 
MEFs using Microarray. 
A number of phenotypic differences have been observed between wild type and 
heterozygous Plk4 MEFs including that heterozygous MEFs exhibit a growth rate 
approaching V2 that of their wild type counterparts (Ko et al., 2005). In addition, 
heterozygous MEFs present an increase in the number of cells with multiple centrosomes 
which have the potential to lead to abnormal chromosome alignment and segregation (Ko 
et ah, 2005). These abnormalities have been proposed as a mechanism that leads to 
genomic instability and the observed increase incidence of tumor development in aged 
heterozygous Plk4 mice in comparison to the wild types. Therefore, it was of interest to 
study the effect of lower Plk4 levels on the expression pattern of other genes. We 
measured the global transcriptional differences between wild type and heterozygous 
MEFs using microarray technology using RNA samples isolated from both Plk4 wild 
type and heterozygous MEFs using three microarray replicates were performed. The 
experiments were performed at the University Health Network (UHN) Microarray facility 
using Mouse 22.4k cDNA arrays using an indirect labeling methodology. Scanned TIFF 
images of both the Cy3-labeled and Cy5-labeled were received from UHN and analysis 
was performed. 
Quantification of results was performed using ScanArray Express v.3.0 (Perkin 
Elmer). Cy3-labeled and Cy-5 labeled images were loaded on the ScanArray Express 
Software producing a composite image of the array (Figure 5). A QuantArray microarray 
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gene annotation file was obtained from the University Health Network (UHN) 
Microarray Centre website indicating the identification of each spot on the array 
(http://www.microarrays.ca/products/glists.html). Using the template obtained from the 
gene list, a grid overlay was designed of the microarray spots and was aligned with the 
scanned image. Quantification was performed by the ScanArray Express software to 
measure the intensity of the hybridization of both the Cy3 and Cy5 labeled samples to its 
complement on the chip. Locally Weighted Scatter Plot Smoother (LOWESS) 
normalization was performed to account for any intensity dependent effects that may 
occur when differences in log ratio values are observed (Quackenbush, 2001). The 
resulting quantification and normalization of the data produced a data file that allowed 
transfer to "The Institute for Genomic Research" (TIGR) TM4 microarray data analysis 
suite for further analysis. Further normalization and filtering of the data was performed 
using the TIGR Microarray Data Analysis System (MIDAS) application. Analysis of all 
microarray data sets for the different microarray experiments (ex. Wild type Plk4 MEFs 
vs Heterozygous Plk4 MEFs) were performed independently. Initial filtering of the data 
was performed. Spots were removed from downstream analysis if an intensity value for 
either the Cy3-labeled or Cy5-labeled spot were invalid (an intensity less than 1). Next, 
flag filtering was performed to remove invalid spots from further analysis. For example, 
if the Cy-3 or Cy5 samples had an intensity of 0 non-saturated pixels within a spot, the 
spot was removed. Subsequently, background filtering was employed. If the background-
corrected intensity of a spot was greater than or equal to the background intensity for 
both the Cy3 and Cy5 labeled samples than the spot was kept in the data set for further 
downstream analysis. 
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Figure 5: Composite View of Cy3 and Cy5 Labeled Microarray 
The wild type Cy3 labeled cDNA was scanned at 532nm causing the Cy3 fluor to emit at 
570nm, while the heterozygous Cy5 cDNA was scanned at 635nm causing an emission at 
670nm. A composite image was produced by the Scanarray software using the Cy3 and 
Cy5 scanned images. 1) A predominately green spot indicated increased transcript 
abundance in wild type Plk4 MEFs, 2) while a predominately red spot indicated increased 
transcript abundance in heterozygous Plk4 MEFs. 3) A yellow spot indicated equal 
transcript levels between wild type and heterozygous Plk4 MEFs 
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Locfit (LOWESS) normalization was performed with specific parameters set. 
Block LOWESS normalization was applied to the data set meaning that only spots within 
a certain block or grid on the microarray chip contribute to the bias of the spots intensity. 
A smoothing parameter was established at 33 percent to compute the normalization of 
each spot using the LOWESS algorithm. These computations were performed by MIDAS 
with the input that the Cy3 labeled sample (wild type MEFs) was the reference or the 
control and the Cy5 labeled sample (heterozygous MEFs) was the experimental value. 
Next, standard deviation regularization parameters were established ensuring that all 
spots within each block or grid of the microarray chip have the same standard deviation 
with the Cy3 labeled sample being the reference. Spots were then filtered from the further 
analysis based on the raw intensity of the hybridization. The cutoff raw intensity was set 
at 10000 with any spots with intensity lower than this threshold removed from any further 
analysis. 
The normalized and filtered data set was loaded into TIGR Multiexperiment 
Viewer (MEV) for clustering analysis. For clustering, the filtered data from all three 
chips was loaded into MEV simultaneously for clustering to occur. The data set was 
clustered using K-Means clustering. K-means clustering divides the filtered data into 
clusters based on the principle that genes within a cluster are closely related. Genes were 
divided into ten different clusters. Within each cluster, genes having a log ratio value 
greater than 1 or less than -1 on each microarray chip were identified. Genes having a log 
ratio greater than 1 represented genes in the heterozygous MEFs that have at least a two 
fold increase in gene expression. As the wild type MEFs was used as the control, genes 
with a log ratio greater than 1 were classified as up-regulated in the heterozygous MEFs. 
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While, a log ratio less than -1 represented genes in the wild type MEFs that have at least 
a two fold increase in gene expression or are down-regulated in the heterozygous MEFs. 
From the microarray data, 9 genes were identified as having at least a two fold 
decrease in transcript profile in the heterozygous MEFs or were down-regulated in the 
heterozygous MEFs when compared to the wild-type control (Table 1) (Appendix J), 
while 146 genes were identified as having at least a two fold increase in transcript profile 
in the heterozygous MEFs (Table 2) (Appendix K). Cellular function for each gene was 
identified using annotation data from the Pubmed database or the Online Mendelian 
Inheritance in Man (OMIM) database. 
Confirmation of Microarray Results Using RT-PCR 
To confirm the validity of the microarray results, qualitative RT-PCR was 
employed. Three genes classified as having increased transcript profiles in the 
heterozygous MEFs were examined: Wntl inducible signaling pathway protein 1 
(Wispl), Sap30 Binding Protein (SAP30BP), Prohibitin (PHB). 
a) Wispl Expression in Heterozygous Plk4 MEFs 
Wispl over expression has been implicated in cellular morphological 
transformation (Xu et al., 2000) as well as and tumor formation in hepatocellular 
carcinomas (Cervello et al., 2004). In addition, over expression of other Wnt pathway 
proteins have also been implicated in tumor formation. I speculate that over expression of 
Wispl and other Wnt pathway proteins could contribute to tumor formation in 
heterozygous Plk4 mice. To confirm the validity of the microarray results, RT-PCR was 
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performed to compare Wispl expression rates in wild type and heterozygous Plk4 MEFs, 
and subsequently densitometry was performed to measure the quantitative differences. 
RNA was isolated from both wild type and heterozygous MEFs and a reverse 
transcription reaction was performed to produce first strand cDNA. PCR primers for 
Wispl were designed to amplify a product of 150 base pair, while PCR primers for 
glyceraldehyde 3-phosphate dehydrogenase (GAPDH), amplified a product 410 base 
pairs in length and was used as an internal loading control. PCR products amplified from 
cDNA taken at three times points for both Wispl and GAPDH, were performed and 
terminated the PCR in the linear part of the PCR amplification curve. The PCR products 
were resolved on a 2% agarose gel to view their difference in relative abundance in 
the wild type and heterozygous MEFs (Figure 6a). 
Densitometry was performed using the Gene Tools software. Intensity values 
were assigned to the bands for Wispl and GAPDH by the software to eliminate any bias. 
To determine the relative expression of Wispl in the heterozygous MEFs compared to 
wild type, first the ratio of the value for Wispl to GAPDH was taken for each individual 
time point. Next, the ratio of GAPDH to Wispl was determined for the wild type time 
points. The ratio of Wispl to GAPDH for the heterozygous time points was multiplied by 
the ratio of GAPDH to Wispl to determine the relative expression of Wispl in the 
heterozygous MEFs to the Wispl in the wild type MEFs (Appendix B). Densitometry 
was performed for three individual trials of RT-PCR for Wispl. The relative expression 
for Wispl over the three trials was calculated along with the standard error of the mean. 
For the three trials of Wispl, the average change in expression of Wispl over the three 




































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































expression in the heterozygous Plk4 MEFs than in the wild type (Figure 6b). The average 
log ratio from the three microarray chips for Wispl was 1.64 corresponding to an average 
3.28 change increase in expression for Wispl in the heterozygous MEFs. Though the 
change in expression appears to differ substantially from the microarray data to the RT-
PCR data, differences are most likely attributed to the fact that the MEFs used for the 
microarray experiments were different MEFs than the MEFs used for the RT-PCR 
experiments. 
b) SAP30-Binding Protein Expression in Heterozygous Plk4 MEFs 
Preliminary data shows that methylation of the Plk4 gene in heterozygous mice 
occurs at a substantially higher rate than in wild type mice. Therefore, it is hypothesized 
that the transcriptional repression of Plk4 in heterozygous mice contributes to the 
increased incidence of tumorigenesis within these mice. Since SAP30BP binds SAP30 
(Li et ah, 2004), a component of the SIN3 histone deactylase complex, it is plausible that 
the increased methylation status of Plk4 heterozygous mice could be contributed to a 
complex that includes SAP30BP. 
RNA was isolated from both wild type and heterozygous Plk4 MEFs and a 
reverse transcription reaction was performed to produce cDNA. PCR primers for 
SAP30BP amplified a product of 190 base pairs, while GAPDH, used as an internal 
loading control amplified a product of 410 base pairs. PCR products were run at three 
time points for both SAP30BP and GAPDH, while amplification was in the linear part of 
the PCR amplification curve except for cycle 42 for SAP30BP which became saturated. 
PCR products were run on a 2% agarose gel to view the differences in the transcript 
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Figure 6: Wispl Transcript Expression in Heterozygous Plk4 MEFs 
a) RT-PCR was performed over three PCR time points to measure the relative 
quantitative difference in the transcript expression of Wispl in wild type and 
heterozygous Plk4 MEFs. GAPDH was used as an internal loading control, b) 
Densitometry was performed to measure the raw intensity of each band. Values for 
Wispl were normalized to GAPDH and the relative mean expression over three PCR 
trials was graphed. The average increase in transcript expression for Wispl in 
heterozygous Plk4 MEFs was between 1.36 to 1.48 greater than in wild type Plk4 MEFs. 
(NB WT: Wild Type; HET: Heterozygous) 
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Wispl Transcript Profile in Wild Type & Heterozygous MEFs over Three PCR cycles 
profiles of SAP30BP in wild type and heterozygous Plk4 MEFs (Figure 7a). 
Densitometry was used to quantify the differences in transcript expression of 
SAP30BP. The same rationale was used to determine the relative expression of SAP30BP 
in the heterozygous MEFs compared to the wild type MEFs as with Wispl. The ratio of 
SAP30BP to GAPDH was determined for both wild type and heterozygous SAP30 at the 
three different PCR time points. Next, in the wild types, the ratio of GAPDH to 
SAP30BP was determined. This value was multiplied with the SAP30BP to GAPDH 
value for heterozygous S AP30 to get the relative expression in relation to wild type 
SAP30BP (Appendix C). Densitometry was performed on three individual RT-PCR trials 
for S AP30BP. The average relative expression and standard average of the mean was 
calculated for the three RT-PCR trials. For the three trials of SAP30BP, the average 
change in expression of SAP30BP over the three PCR time points was between 1.36 and 
1.81 times greater level of transcriptional expression in the heterozygous Plk4 MEFs than 
in the wild type (Figure 7b). The average log ratio for the three microarray chips was 1.49 
corresponding to an average increase in expression of 2.98 in the heterozygous Plk4 
MEFs. Similar to Wispl, MEFs from different embryos were used for both the 
microarray and the RT-PCR experiments. These differences possibly could contribute to 
the variation in change of expression between the microarray and the RT-PCR. Also, the 
relative expression of SAP30BP decreases in the heterozygous MEFs over the three PCR 
time points due to a result that the PCR product was becoming saturated, and therefore 
not in the linear part of the PCR product amplification curve. 
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c) Prohibitin Expression in Heterozygous Plk4 MEFs 
Prohibitin (PHB) has been implicated to play a role in cellular senescence 
(Rastogi et al., 2006). Since mouse embryonic fibroblasts are primary cell lines, they 
eventually stop dividing and take a senescent phenotype of flattened morphology and 
increased granularity. In heterozygous Plk4 MEFs, the senescent phenotype is observed 
at an earlier passage than in the wild types. Therefore, it is plausible that increased 
prohibitin expression in heterozygous Plk4 MEFs contributes to this observed earlier 
senescent phenotype. 
RNA was isolated from both wild type and heterozygous Plk4 MEFs and a reverse 
transcription reaction was performed to produce cDNA. PCR primers for PHB multiplied 
by the ratio of PHB to GAPDH for the heterozygous time points to determine the relative 
expression of PHB in the heterozygous Plk4 MEFs to the wild type MEFs (Appendix D). 
Densitometry was performed for three individual PCR experiments and 
the average of the relative expression and standard error of the mean were calculated. 
Over three PCR trials, the average mean transcript expression of prohibitin in 
heterozygous MEFs was between 1.83 and 2.37 times greater than in the wild type Plk4 
MEFs (Figure 8b). The average log ratio for the three microarray experiments for 
prohibitin was 1.52 corresponding to an increase in transcript expression of 3.04 times 
greater in the heterozygous MEFs. Similar to Wispl and Sap30BP, MEFs from different 
mice were used for the RT-PCR experiments than for the microarray, possibly explaining 
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Prohibitin Transcript Profiles in Wild Type & Heterozygous MEFs over Three PCR Time Points 
The Effect of Ionizing and Ultraviolet Radiation on the Plk4 Transcript Profile in 
MEFs 
Though it is not yet known whether Plk4 plays a crucial role in response to DNA 
damaging agents, Plk4 has shown to interact with crucial DNA damage proteins 
including p53 (Swallow et al, 2005), Cdc25c (Bonni et al., 2008), ATM, ATR, Chkl and 
Chk2 (Hudson et al, unpublished data). Subsequently, it was of interest to analyzeis the 
effect of DNA damaging agents on the transcript profile of Plk4, and whether there exist 
a difference in transcript expression between wild type and heterozygous MEFs. 
Wild type and heterozygous MEFs were exposed to 25 Gy IR or 40 mJ/cm2 UV. 
RNA was isolated at various time points and RT-PCR was performed to visualize if there 
were differences in transcript expression. PCR primers for Plk4 amplified a PCR product 
of 310 base pairs, while GAPDH, used as an internal loading control amplified a product 
410 base pairs. PCR products were amplified at three time points in the linear range of 
the PCR amplification curve. PCR products were run on a 2% agarose gel to visualize 
differences between the wild type and heterozygous Plk4 MEFs in response, first to IR 
then to UV. 
Densitometry was performed to quantitate the transcriptional difference between 
wild type and heterozygous Plk4 MEFs. The control with no exposure was used as a base 
line with the subsequent time points normalized back to it. Densitometry for both wild 
type and heterozygous samples was done separately and differences were visualized 
using a graph. Briefly, for each time point post exposure to DNA damage, and each PCR 
cycle time point, a ratio of Plk4 to GAPDH was determined. Then for the control with no 
exposure, a ratio of GAPDH to Plk4 was determined. The relative expression was 
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determined by multiplying the Plk4 to GAPDH ratio for time points post exposure to the 
ratio of GAPDH to Plk4. Densitometry was performed for three individual PCR 
reactions. The average relative expression was determined along with the standard error 
of the mean. Subsequently, the values for the heterozygous MEFs were normalized back 
to the wild type MEFs as RNA levels in the wild type MEFs are expressed twice as much 
as in heterozygous MEFs (Swallow et al., 2005). 
In response to IR, the Plk4 transcript profile of the wild type MEFs stays constant 
until one hour post exposure when levels declined to between 60-70% relative to the 
control. These levels continue to remain at this decreased level 24 hours post irradiation 
(Figure 9a) (Appendix E). Similarly, for the heterozygous MEFs in response to IR, the 
Plk4 transcript profile remains constant till one hour post exposure, until a similar decline 
in transcript expression is observed. Between 2 and 24 hours post irradiation, the Plk4 
transcript levels were between 60-70% relative to the control (Figure 9b) (Appendix F). 
When a comparison between wild type and heterozygous MEFs at the first PCR time 
point is observed, there is no comparable difference between Plk4 transcript profiles 
(Figure 9c). When a comparison of the Plk4 transcript profile at the second PCR time 
point is examined, the differences in transcript profile 2 hours post exposure for both the 
wild type and heterozygous MEFs is 70-90% relative to the control (Figure 9d). At the 
third PCR time point, observable differences between wild type and heterozygous 
transcript profile appear (Figure 9e). The difference for the heterozygous MEFs for all 
time points is within the standard error relative to the control. This is most likely due to 
the PCR amplification being in the non-linear part of the amplification curve. Subsequent 
differences are noticed between wild type and heterozygous transcript profile. At one 
68 
Figure 9: Effect of Ionizing Radiation on the Transcript Profile of Plk4 in Wild 
Type and Heterozygous MEFs 
Wild type and heterozygous MEFs were exposed to 25 Gy ionizing radiation (IR), and 
RNA was isolated at various time points post exposure. RT-PCR was performed to 
measure the relative quantitative difference in Plk4 expression after exposure in both wild 
type and heterozygous MEFs. GAPDH was used as an internal loading control. PCR 
cycles for GAPDH were 28, 30, 32 cycles while for Plk4 38, 40, 42 cycles. Within each 
time post IR exposure, PCR products over three PCR cycles is shown corresponding to 
the number of cycles for GAPDH and Plk4 a) For wild type MEFs, in response to IR, 
Plk4 transcript levels remain constant until lhr post radiation when a reduction in levels 
is observed to between 60-70% relative to the control, b) Similarly, for heterozygous 
MEFs, Plk4 transcript levels remained constant until lhr post radiation when a decrease 
to 60-70% relative to the control was observed, c) Densitometry was performed to 
measure the raw intensity for each band. Values for Plk4 were normalized to GAPDH, 
and subsequently values for the heterozygous MEFs were normalized to the wild type to 
determine the mean relative expression over the three PCR time points. For the first PCR 
time point, there is no comparable difference between the wild type and heterozygous 
Plk4 transcript levels, d) At the second PCR time point, the difference in transcript levels 
between wild type and heterozygous is minimal, e) At the third PCR time point, 
differences are apparent between the transcript profiles of Plk4 in wild type and 
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Comparison of Plk4 Transcript Levels in Wild Type & Heterozygous MEFs after Exposure to 
25 Gy Ionizing Radiation: First PCR Time Point 
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hour to 24 hours post exposure to IR, the transcript profile is 70-90% relative to the 
control. Most likely, in correlation with the first PCR time point, levels of Plk4 for both 
the wild type and heterozygous MEFs drop to around 70% relative to the control. 
Upon exposure to UV, there is a striking difference in transcript profile levels of 
Plk4 between wild type and heterozygous MEFs. In the wild types, upon exposure to UV, 
levels of Plk4 are undetectable. At 2 hours post UV exposure levels reappear to the level 
of the control, then increase to 40% greater expression than is observed in the control 
(Figure 10a) (Appendix G). Unfortunately, at a dosage of 40 mJ/cm2, the majority of cells 
undergo apoptosis, so levels of Plk4 at 24 hours were unable to be determined. In 
contrast, upon exposure to UV, no levels of Plk4 were detected in the heterozygous 
MEFs at any time (Figure 10b) (Appendix H). Similarly, to the wild type MEFs, the 
heterozygous MEFs undergo apoptosis prior to 24 hours post exposure. The results for 
the wild type and heterozygous Plk4 transcript profiles are consistent across all three 
PCR time points (Figure 10c,d,e). In the heterozygous MEFs in response to UV, the 
levels of Plk4 are undetectable. Therefore, it is plausible that since there is only one dose 
of the Plk4 gene in heterozygous MEFs, that Plk4 is transcribed at such low levels that it 
is undetectable by the conditions of PCR that were run. Since levels of wild type Plk4 
increased relative to the control 4 to 8 hours post UV exposure, it could be hypothesized 
that Plk4 plays a dispensable role in apoptosis. 
The Effect of Ionizing and Ultraviolet Radiation on Plk4 Protein Levels in MEFs 
As RNA transcript levels do not necessarily correlate with protein levels, Plk4 
protein levels in wild type and heterozygous MEFs were examined to determine if there 
73 
Figure 10: Effect of Ultraviolet Radiation on the Transcript Profile of Plk4 in Wild 
Type and Heterozygous MEFs 
Wild type and heterozygous MEFs were exposed to 40mJ/cm2 ultraviolet radiation (UV), 
and RNA was isolated at various time points post exposure. RT-PCR was performed to 
measure the relative quantitative difference in Plk4 expression after exposure in both wild 
type and heterozygous MEFs. GAPDH was used as an internal loading control. PCR time 
points for GAPDH were 28, 30, 32 cycles while time points for Plk4 were 38, 40, 42 
cycles. Within each time post UV exposure, PCR products over three PCR cycles is 
shown corresponding to the number of cycles for GAPDH and Plk4a) In response to UV, 
Plk4 transcript levels in wild type MEFs decrease to undetectable levels immediately 
after exposure. At 2hrs post exposure, Plk4 levels start to continually increase to levels 
greater than observed in the control, b) In contrast, levels of Plk4 are completely 
undetectable in heterozygous MEFs upon exposure to UV through to 8hrs post exposure, 
c) Densitometry was performed to measure the raw intensity for each band. Values for 
Plk4 were normalized to GAPDH, and subsequently values for the heterozygous MEFs 
were normalized to the wild type to determine the mean relative expression over three 
PCR time points and the results were graphed. For all three PCR time points (c, d, e), 
both wild type and heterozygous Plk4 levels decrease after exposure to UV. But at two 
hours, levels of Plk4 in wild type MEFs increase and continue to increase to levels 
greater than control, while heterozygous Plk4 levels remain undetectable. (NB WT: Wild 
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is a difference in response to both ionizing and ultraviolet radiation. Wild type and 
heterozygous Plk4 MEFs were exposed to 25 Gy IR and 40mJ/cm2 UV, lysed 6hr post 
exposure, and the cell extracts were subjected to Western Blot analysis. For both wild 
type and heterozygous MEFs, levels of protein expression do not change when the MEFs 
were exposed to either IR or UV; 6 hours post exposure (Figure 11). GAPDH was used 
as a loading control to ensure equal protein loading. Though, it is apparent that protein 
levels in heterozygous MEFs are half the level present in wild type MEFs. This finding 
supports previous evidence presented by Swallow et al, 2005. 
The Effect of PIk4 Gene Dosage on Protein Levels of DNA Damage Proteins 
Plk4 is able to interact with a number of DNA damage and DNA repair proteins 
including Cdc25c, Chkl, Chk2, Cyclin Bl, p53 and Gadd45a, and in the case of Cdc25c 
(Bonni et al., 2008), Chk2 (Hudson, unpublished data) and p53 (Swallow et al., 2005) is 
able to phosphorylate these proteins. It was interesting to determine whether there is a 
difference in protein levels in wild type and heterozygous Plk4 MEFs in response to 
DNA damage. Wild type and heterozygous Plk4 MEFs were exposed to 25 Gy IR or 
40mJ/cm2 UV, lysed 6hr post exposure, and the cell extracts were subjected to Western 
Blot analysis. Results displayed are the representative data from three experiments. 
Cdc25c is the phosphatase responsible for removing the inhibitory phosphates from the 
cyclin Bl/Cdkl complex, promoting its activation and initiating the G2/M transition. 
When protein levels of Cdc25c were observed in wild type and heterozygous Plk4 MEFs, 
in general there is no difference in levels of Cdc25c (Figure 12a). Interestingly, the levels 
of Cdc25c do not change in response to IR or UV relative to the control. Also, there is no 
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Figure 11: Plk4 Protein Levels do not Change in Response to IR or UV 
Wild type and heterozygous Plk4 MEFs were exposed to either 25 Gy ionizing radiation 
(IR) or 40mJ/cm2 ultraviolet radiation (UV) and lysed 6 hr post exposure to obtain whole 
cell lysates. The lysates were run on SDS Page gel and then subjected to Western blot. 
The blots were probed with an anti-Plk4 antibody and with an anti-GAPDH antibody, as 
a control to ensure equal protein loading. No difference in Plk4 protein levels were 
observed for either wild type or heterozygous MEFs in response to IR or UV. Plk4 
protein levels in heterozygous MEFs were approximately half the observable level than in 
wild type MEFs. (NB WT: Wild Type; HET: Heterozygous) 
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observable change in Cdc25c levels in response to DNA damage between wild type and 
heterozygous MEFs. GAPDH was used as a loading control to ensure equal protein 
loading and it is used in all subsequently experiments with additional proteins. 
Chkl is a signal transducer protein activated in response to DNA damage (Abraham, 
2001). When Chkl levels were examined, there is no detectable difference between wild 
type and heterozygous Chkl protein levels (Figure 12b). Strikingly, there was no increase 
in protein level in either the wild type or heterozygous MEFs in response to IR. Similarly, 
there was no change in protein level in cells exposed to UV. 
Chk2 is another signal transducer protein activated in response to DNA damage 
(Matsuoka et ah, 2000). In general, Chk2 levels in heterozygous MEFs appear to be 
greater than in the wild type (Figure 12c). While in response to UV, levels of Chk2 are 
elevated in both the wild type and heterozygous MEFs. Interestingly, levels of Chk2 are 
also elevated in response to IR, indicating that there is some degree of cross talk between 
the IR and UV DNA damage pathways. 
Activation of the cyclin Bl/Cdkl complex is necessary for the G2/M transition to 
occur (Bassermann et al., 2005). In general, cyclin Bl levels in heterozygous MEFs are 
significantly lower than those observed in the wild types (Figure 12d). While in response 
to UV, both wild type and heterozygous levels of cyclin B1 are decreased proportionately 
to the levels observed in the controls. In contrast, levels observed with IR exposure are 
similar to levels of cyclin Bl seen with their respective controls. 
The tumor suppressor protein, p53 is considered the "guardian of the genome for the 
numerous cellular functions it performs (Efeyan and Serrano, 2007). p53 plays a crucial 
role in the cells response to genotoxic stress by initiating DNA damage pathways. In 
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Figure 12: Differences in Protein Levels of DNA Damage Proteins in PIk4 MEFs 
Wild type and heterozygous Plk4 MEFs were exposed to either 25 Gy ionizing radiation 
(IR) or 40mJ/cm2 ultraviolet radiation (UV) and lysed 6 hr post exposure to obtain whole 
cell lysates. The lysates were run on SDS Page gel and then subjected to Western blot 
analysis. GAPDH was used to ensure equal protein loading, a) No change in Cdc25c 
levels were observed in response to IR or UV. b) In response to IR or UV, no observable 
differences in Chkl protein levels were observed, c) Chk2 levels are elevated in 
heterozygous MEFs in comparison to the wild types, while in response to both IR and 
UV in both type of MEFs Chk2 levels increase, d) In general, cyclin Bl levels are lower 
in heterozygous MEFs than wild types. In addition, for both wild type and heterozygous 
MEFs, cyclin Bl levels decrease in response to UV. e) Levels of p53 are increased in 
heterozygous MEFs in general and in response to UV, while levels are constant in both 
wild type and heterozygous MEFs in response to IR. f) Gadd45a levels are increased in 
heterozygous MEFs and in response to IR, while no induction of Gadd45a is observed in 
wild type MEFs. (NB: WT: Wild Type; HET: Heterozygous) 
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response to DNA damage, p53 expression is crucial to blocking cell cycle progression 
until the DNA is repaired or apoptotic pathways are initiated (Bunz et al., 1999). In Plk4 
MEFs, there is a sharp contrast between wild type and heterozygous MEFs, with levels of 
p53 protein expression substantially higher in the heterozygotes. A similar finding is 
observed in response to UV. In contrast, levels of p53 are similar for both wild type and 
heterozygous samples when exposed to IR (Figure 12e). 
The growth arrest and DNA damage-inducible gene (Gadd45a) expression is 
induced by DNA damage and growth arrest signals (Zhan, 2005). In Plk4 MEFs, 
Gadd45a expression is significantly higher in heterozygous than wild type MEFs. No 
Gadd45a induction is observed in wild type MEFs in response to either IR or UV. Levels 
of Gadd45a are similar to the wild type control. Interestingly, Gadd45a expression is 
elevated in heterozygous control and IR exposed MEFs. In comparison to the 
heterozygous control MEFs, no increase in Gadd45a expression levels occurred in the 
UV exposed MEFs (Figure 12f). 
Apoptotic Rate for Plk4 MEFs in Response to UV 
In response to 40 mJ/cm2 of ultraviolet radiation, a significantly high percentage 
of both wild type and heterozygous MEFs undergo apoptosis before 24 hours. Therefore, 
to determine whether there was a difference between susceptibility, a TdT-mediated 
dUTP Nick-End Labeling (TUNEL) assay was performed. Wild type and heterozygous 
MEFs were grown on glass cover slips, exposed to 40 mJ/cm2 of UV and a TUNEL assay 
performed 0, 1,2, 4, 6, 8 hours post exposure. DNase I treatment was used as a positive 
control as the enzyme induces fragmentation of DNA similar to what is observed in 
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apoptotic cells. The cells were stained red with propidium iodide (PI) to locate the nuclei, 
while staining green with fluorescein- 12-dUTP was indicative of apoptotic cells (Figure 
13a) 200 cells were counted per slide and the percentage of apoptotic cells per slide was 
determined. Three trials at each time point were performed and the average percentage of 
apoptotic cells and the standard error of the mean was determined (Figure 13b) 
(Appendix I). 
In response to UV, there was a no significant difference in susceptibility to 
apoptosis between wild type and heterozygous MEFs. At 0 and 1 hour post exposure, no 
apoptotic cells were observed; similar to what was seen in MEFs exposed to no UV. At 2 
hours post exposure, between 5 to 10% of the cells were apoptotic, though there was no 
statistical difference between wild type and heterozygous MEFs. The percentage of 
apoptotic cells at 4 hours increased to 20%, again with no statistical difference. At 6 
hours post exposure, there appears to be a difference in susceptibility with 28% of wild 
type MEFs with 37% of heterozygotes apoptotic. At 8 hours, 65% of both wild type and 
heterozygous cells were apoptotic. The only statistical difference in apoptotic rate 
between the wild type and heterozygous MEFs was observed at 6 hours. 
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Figure 13: No Difference in Apoptotic Susceptibility between Wild Type and 
Heterozygous MEFs 
Wild type and heterozygous MEFs were exposed to 40mJ/cm of ultraviolet radiation 
(UV) and a TUNEL assay was performed at various time points post exposure a) Cells 
were stained red with propidium iodide (PI) to identify the nucleus, while green staining 
with TUNEL was indicative of apoptotic cells. DNase I treatment was used as a positive 
indicator of apoptotic cells, b) As time post exposure increased, there was a greater 
percentage of both wild type and heterozygous MEFs susceptible to apoptosis. Though, 
no statistical differences between susceptibility rates of apoptosis were observed. 
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Comparison between Transcript Profiles in Wild Type and Heterozygous Plk4 
MEFs in Response to UV using Microarray. 
In response to ultraviolet radiation (UV), the transcript profiles for Plk4 differ 
significantly between wild type and heterozygous. After exposure to UV, transcript 
profiles in heterozygous MEFs decline significantly in comparison to control levels. In 
contrast, in wild type MEFs after an initial decline in Plk4 transcript levels, levels 
increase after 2 hours exposure and continue to increase. Therefore, it was of interest to 
investigate transcript profiles of other genes in response to UV. 
Both wild type and heterozygous MEFs were exposed to 40mJ/cm2 and RNA was 
isolated 4 hours post exposure to UV. The RNA was sent to the UHN Microarray Centre 
where three microarray replicates were performed using an indirect labeling 
methodology. A face to face hybridization using a Mouse 7.4k and Mouse 15k 
microarray chips was performed. A QuantArray microarray gene list was obtaining from 
the University Health Network (UHN) Microarray Centre website indicating the 
identification of each spot on the Mouse 7.4K and Mouse 15k array 
(http://www.microarrays.ca/products/glists.html). Quantification and analysis of the 
microarray chips was done in a similar method as previously stated. To obtain differences 
in transcript profiles between the wild type and heterozygous MEFs, the analysis of the 
Mouse 7.4k and Mouse 15k array were performed separately. Similarly to the previous 
microarray, genes were identified with a log ratio equal or greater than 1, corresponding 
to genes within the heterozygous MEFs that have at least a 2 fold or greater rate of 
transcript expression than in the wild type MEFs. These genes were up-regulated in the 
heterozygous MEFs. Genes identified with a log ratio equal of less than -1 , corresponded 
89 
to genes having at least a 2 fold or greater rate of transcript expression or were down-
regulated in the heterozygous MEFs. 
From the microarray data, 27 genes were identified as having at least a two fold 
increase in transcript profile or were down-regulated in the heterozygous MEFs 4 hours 
post exposure to UV (Table 3) (Appendix L), while 84 genes were identified as having at 
least a two fold increase in transcript profile in the heterozygous MEFs 4 hours post 
exposure to UV, or were up-regulated in the heterozygous MEFs (Table 4) (Appendix J). 
Cellular function for each gene was identified using either Pubmed database or the 



































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Comparison between Transcript Profile in Wild Type vs. Wild Type UV Exposure 
and Heterozygous vs. Heterozygous UV Exposure Using Microarray 
The data from the two microarray experiments was analyzed to determine 
differences in transcript profile, firstly in the wild type vs. wild type MEFs 4 hours post 
UV exposure; and secondly for the heterozygous vs. heterozygous MEFs 4 hours post 
UV exposure. Since a substantial percentage of the MEFs exposed to UV were destined 
for apoptosis, the analysis would provide a general survey of differences in cellular 
mechanics between normal and apoptotic MEFs. 
Since the two different microarray experiments were performed using chips with 
different formats, similar analysis to the previous two microarray experiments couldn't be 
performed. Instead, data for each cyanine labeled sample was quantified individually, 
unlike the previous two experiments where a composite of the Cy3 and Cy5 image were 
quantified together. Quantification was performed using LOWESS normalization within 
the ScanArray Express Software. From this normalization, data was removed from 
analysis if the raw intensity was not at least two standard deviations above the 
background. Secondly, data was removed if the minimum signal to noise ratio was not 
greater than 200. The parameter of signal to noise ratio uses the ratio of the spot intensity 
to the standard deviation of the local background of all spots on the microarray. The data 
was transferred to MEV where a low intensity cutoff of 100 000 was used to further 
streamline the data. In order to determine differences in transcript profile, the raw 
intensity values for the three non UV exposure chips were compared to the raw intensity 
values of the UV exposure chips. To eliminate possible error in selecting candidate genes 
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due to variance between raw intensity values between the three chips of one treatment, 
genes with at least a three fold increase in raw intensity were selected. 
For the comparison of normal wild type MEFs versus wild type MEFs exposed to 
UV, 171 genes were identified with at least a three fold greater raw intensity, or being up-
regulated in the normal wild type MEFs (Table 5). Conversely, 83 genes were identified 
as having at least a three fold greater expression in the wild type MEFs 4 hours post UV 
exposure, or being down-regulated in the normal wild type MEFs (Table 6). Comparing 
the normal heterozygous MEFs to heterozygous MEFs 4 hours post UV exposure, 151 
genes were observed with at least a three fold increase in raw intensity, or being up-
regulated in the normal heterozygous MEFs (Table 7). While 24 genes were identified as 
having at least a three fold increase in expression in the heterozygous MEFs 4 hours post 
UV exposure, or being down-regulated in the normal heterozygous MEFs (Table 8). 
Cellular function for each gene was identified using either Pubmed database or the 
Online Mendelian Inheritance in Man (OMIM) database. 
The analysis from this microarray experiment was compared to the other two 
microarray experiments (wild type vs. heterozygous MEFs; UV wild type vs. UV 
heterozygous MEFs) and there was no overlap between the genes that were up- or down-
regulated in the experiments. Though, from the comparisons in this experiment (wild type 
MEFs vs. UV wild type MEFs; heterozygous MEFs vs. UV heterozygous MEFs), there 
were 56 genes that were up-regulated in both the wild type and heterozygous MEFs, 
while 115 genes in just the wild type MEFs and 95 genes in just the heterozygous MEFs 
were up-regulated. Similarly, 19 genes were up-regulated in both the wild and 
95 
heterozygous MEFs exposed to UV, while 64 genes were up-regulated in just the UV 

























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Transcript Analysis in Wild Type and Heterozygous Plk4 MEFs 
Wild type and heterozygous Plk4 MEFs exhibit a number of phenotypic 
differences including a slower proliferation rate and increased centrosomal number 
leading to chromosomal misalignment and improper segregation in heterozygotes (Ko et 
al, 2005). It can be hypothesized that these cell cycle abnormalities lead to the increased 
incidence of tumor formation observed in the heterozygous mice. In this study, murine 
embryonic fibroblasts (MEFs) derived from approximately 12.5 day old embryos were 
used as a model to examine the effect of lower Plk4 levels on the expression pattern of 
other genes. Both wild-type and heterozygous Plk4 MEFs were used as they are both 
viable. Since Plk4 nulls spontaneously abort at E7.5, the use of MEFs from this genotype 
was not an option. In order to examine the nature of these global differences a microarray 
based approach was utilized. MEFs were used to do the microarray and subsequent 
confirmation via RT-PCR because they are easier to manipulate and provide a strong 
reference point to compare differences between the wild type and heterozygous Plk4 
phenotype. Analysis done within the MEFs would provide clues to possible differences 
that may exist within adult cells. 
It was determined that 9 genes contained at least a two fold decrease in 
transcriptional expression in the heterozygous MEFs (Table 1), while 146 genes were 
identified that had at least a two fold increase in transcriptional expression in the 
heterozygous MEFs (Table 2). Three candidate genes were picked for further analysis 
that may potentially contribute to the malignant phenotype seen in adults. This is 
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discussed in more detail below. Specifically, a RT-PCR densitometry based approach 
was used to re-examine that the relative expressions of Wisp 1 (Figure 6), SAP30 Binding 
Protein (Figure 7), and Prohibitin (Figure 8) were greater in heterozygous than wild type 
MEFs. The results obtained through RT-PCR analysis parallel the microarray data 
observed. 
i) Wispl Expression in Heterozygous MEFs 
Wntl-inducible signaling pathway protein 1 (Wispl) is a member of the 
connective tissue growth factor family (CCN). It was first identified as being upregulated 
in Wntl-transformed mouse mammary epithelial cells and elevated levels were present in 
colon cancer (Pennica et al., 1998). Additionaly, aberrant Wnt signaling has been 
implicated in the development of hepatocellular carcinomas (HCC) (Lee et al., 2006), 
and Wispl (Cervello et al., 2004) over expression has been characterized in HCC. It is 
plausible to believe that aberrant Wnt regulation and Wispl over expression could 
contribute to the increased incidence of HCC observed in heterozygous mice. 
Wispl activity is transcriptionally regulated by both Wntl and p-catenin. In addition, 
Wntl and P-catenin regulated over expression of Wispl contributes to increased 
morphological transformation and accelerated cell growth. Also, over expression of 
Wispl in nude mice contributed to tumor formation, therefore promoting Wispl as an 
oncogene (Xu et al., 2000). Wispl over expression has been implicated in additional 
malignancies including scirrhous gastric carcinoma (Tanaka et al., 2001), breast cancer 
(Xie et al., 2001), and cholangiocarcinoma (Tanaka et al., 2003). Interestingly, Wispl 
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also attenuates p53-mediated apoptosis through the Akt/PKB signaling pathway (Su et 
al, 2002). 
Members of the CCN family contain four conserved modules present in other 
unrelated extracellular proteins. One of the modules is a thrombospondin domain (Lau 
and Lam, 1999). Interestingly, thrombospondin was one of the genes that also contained 
increased transcript expression in heterozygous MEFs. Thrombospondin is a potent 
inhibitor of angiogenesis, which is crucial for the growth and metastasis of tumors. 
Thrombospondin expression is positively regulated by p53 (Dameron et al., 1994). Loss 
of wild type p53 leads to a loss of thrombospondin expression and the development of an 
angiogenic phenotype (Volpert et al., 1997). Though no direct interaction has been 
shown between Wispl and thrombospondin, it could be interesting to speculate that 
Wispl could bind to thrombospondin, inhibiting its function, promoting angiogenesis and 
tumor formation. 
In addition, in response to DNA damage, data shows that Wispl can attenuate p53 
mediated apoptosis through the activation of the Akt pathway (Su et al., 2002). Wispl 
activation of Akt allows Akt to block the release of cytochrome c from the mitochondria 
(Kennedy et ah, 1999), preventing cytochrome c activation of the caspases which would 
lead to apoptosis (Gottlob et al., 2001). Also, expression of Wispl upregulates BC1-XL 
activity. BC1-XL has been shown to interact with caspase-9 (Pan et al., 1998) and Apaf-l 
(Hu et al., 1998) resulting in inhibition of caspase activity. In addition, BC1-XL also can 
block cytochrome c release from the mitochondria, preventing apoptosis (Kharbanda et 
al, 1997). 
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Interestingly, in the microarray data, phosphatidylinositol 3-kinase (PI3K) was 
also over expressed in the heterozygous MEFs. PI3K has shown to be an upstream 
regulator of Akt (Nicholson and Anderson, 2002). Wispl activation of Akt and BC1-XL 
pathways along with PI3K activation of Akt provides a mechanism within the 
heterozygous MEFs to overcome apoptotic pathways in response to DNA damage. 
Therefore, it is likely that genetic instability becomes prevalent leading to possible 
tumorigenesis and the increased incidence of tumors observed in heterozygous mice. 
Wispl was first identified as a Wntl and P-catenin induced oncogene (Xu et al, 
2000). Though the exact method of Wispl activation has yet to be elucidated, it is known 
that activation of Wnt target genes occurs through P-catenin. p-catenin forms a complex 
with the T-cell factor/lymphocyte enhancing factor (TCF/LEF) family of transcription 
factors to activate the expression of target genes (Polakis, 1999). Interestingly, TCF4 also 
came up as being over expressed in heterozygous MEFs. Though the transcription factor 
responsible for the activation of Wispl is yet to be known, it is interesting to speculate 
that TCF4 may be responsible as both were observed as being over expressed in 
heterozygous MEFs. 
Along with Wispl (Cervello et al, 2004), TCF4 (Zhao et al, 2004) over 
expression has also been implicated in the development of HCC. It is plausible to believe 
that aberrant Wnt regulation could contribute to the increased incidence of HCC observed 
in heterozygous mice. It has been established that Wispl expression blocks p53 mediated 
apoptosis (Su et al, 2002). Heterozygous Plk4 MEFs present a number of abnormal 
phenotypes including abnormal centrosome number leading to improper chromosome 
segregation (Ko et al, 2005). Therefore, it seems plausible that heterozygous MEFs may 
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be unable to undergo p53 mediated apoptosis due to over-expression of Wisp 1. It is 
possible that a similar phenotype as seen in the heterozygous MEFs may occur in adult 
cells. Without apoptosis occurring, these cells continue to go through the cell cycle 
leading to a greater number of cells with abnormalities and greater genomic instability 
which eventually will contribute to tumor formation. 
ii) SAP30 Binding Protein Expression in Heterozygous MEFs 
Epigenetic modification to genes has been well documented as a method to 
promote oncogenesis within the cell. Since heterozygous mice develop cancer at a rate 
significantly higher than there wild type littermates, it has been hypothesized that 
epigenetic silencing of Plk4 could be a possible mechanism for the increased incidence of 
tumorigenesis observed. Plk2 has been implicated in mediating apoptosis as a target gene 
of p53, though epigenetic silencing of Plk2 transcriptional expression via methylation is a 
common occurrence in B cell lymphomas (Smith et al, 2006). While epigenetic silencing 
of Plkl or Plk3 has not been characterized, preliminary evidence suggests that Plk4 in 
heterozygous mice livers undergoes methylation in the CpG island region of its promoter 
at a significantly higher rate than wild types. Methylation of Plk4 has also been observed 
in the liver tumors of heterozygous mice. Methylation of the Plk4 promoter increases 
with age and is more frequent in male mice. Additionally, chronic alcohol exposure has 
been implicated to promote methylation (Kim and Shukla, 2006). Heterozygous MEFs 
become methylated upon exposure to a lower concentration of ethanol than wild types 
(Ward, Hudson unpublished data). 
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Though little is known about the function of SAP30 binding protein (SAP30BP), 
it has been determined that SAP30BP binds to SAP30, a component of the Sin3 histone 
deactylase complex (Sin3-HDAC) (Li et al, 2004). The Sin3-HDAC complex is 
primarily responsible for deacetylating nucleosomes in Sin3 regulated promoters, 
resulting in repressed chromatin structure and transcriptional silencing (Kuzmichev et al., 
2002). In addition, through the enzymatic function of Sin3, the Sin3-HDAC complex can 
also participate in DNA methylation, N-acetylglucoseamine transferase activity, and 
histone methylation. The Sin3-HDAC lacks DNA-binding capacity, so therefore it must 
be targeted to gene promoters by DNA-binding proteins (Silverstein and Ekwall, 2005). 
In yeast, SAP30 has the ability to recruit the complex to the gene promoters, but as yet 
this function hasn't been established in mammals (Zhang et al., 1998). Therefore, though 
the structure of SAP30BP has yet to be elucidated, it is interesting to speculate that 
SAP30BP could contain a DNA-binding domain to target the Sin3-HDAC complex to the 
promoter region. 
In addition, p53 is able interact with TATA box binding-protein (TBP) to 
facilitate the recruitment of Sin3-HDAC complex to the gene promoter for transcriptional 
repression (Farmer et al., 1996). Li et al, 2005 found that in response to DNA damaging 
agents, p53-mediated transcriptional repression of Plk4 occurs through the activity of 
HDAC. p53 regulates not only DNA damage pathways but also the mitotic spindle 
checkpoint. Previous work showed that in heterozygous Plk4 hepatocytes there was a 
significant increase in multipolar spindle complexes with aberrant mitosis (Ko et al., 
2005). The mitotic spindle checkpoint is necessary to ensure proper mitotic spindle 
formation, so that inaccurate chromosomal segregation does not occur (Xie et al., 2005). 
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Therefore, it could be hypothesized that methylation of Plk4 occurs in a p53-mediated 
manner and consequently could inhibit oncogenesis. 
Methylation and other epigenetic modifications are responsible for altering 
chromatin structure. Preliminary evidence shows that Plk4 is methylated, though the 
functional cascade responsible for this methylation is unknown. Li et al., 2005 showed 
that Plk4 undergoes repression in a p53-mediated manner through HDAC. Plk4 is able to 
interact and phosphorylate p53 on Ser-293 (Swallow et al., 2005), though the functional 
significance of this interaction is unknown. Observed results within the heterozygous 
MEFs show that p53 levels are significantly greater than in the wild types (Figure 13e). 
Therefore, it can be hypothesized that with lower levels of Plk4 in heterozygous MEFs, 
Plk4 is unable to phosphorylate p53 to the extent that wild type Plk4 can; thus p53 
function is not inhibited in the heterozygous MEFs. This could explain the increase in 
methylation observed in heterozygous mice livers, as p53 which is not inhibited by Plk4 
is able to inhibit Plk4 function through methylation. 
iii) Prohibitin Expression in Heterozygous MEFs 
Cellular senescence occurs when normal cells lose their ability to divide and is 
indicative of cells with a flattened morphology and an increased granularity phenotype 
(Campisi, 2001). These phenotypes are observed at a greater frequency and at an earlier 
passage in heterozygous Plk4 MEFs than in wild types. 
The cellular senescent phenotype is observed when shortening of the telomeres is 
recognized by the cell as a DNA double strand break, and DNA damage pathways are 
initiated. ATM/ATR mediate the activation of cell-cycle checkpoints associated with 
110 
cellular senescence, mainly via p53, CHK1 and CHK2, with the participation of p21, pl6 
and retinoblastoma protein (RB) (Schmitt et al., 2007). RB function has been deemed 
necessary for inducing senescence (Lowe and Sheer, 2003). RB has been shown to 
interact with various transcriptional co repressors including heterochromatin protein 1 
(HP1) (Narita et al., 2003), histone deacetyase 1 (HDAC1) (Brehm et al., 1998), DNA 
methyltransferase (Vandel et al., 2001), Polycomb proteins (Ross et al., 1999), and 
chromatin-remodeling complexes Brg and Brm (Strober et al., 1996) to repress E2F 
transcription factor (E2F) transcriptional activity. E2F activity is essential for cell 
proliferation and its reduction immediately provokes cellular senescence (Maehara et al., 
2005). 
Prohibitin has been implicated to play a crucial role in cellular senescence though 
the mechanism has yet to be elucidated (Dell'Orco et al., 1996). It is believed that 
prohibitin's role in senescence acts through its ability to repress E2F transcription factor 
1 (E2F1) mediated transcriptional activity (Wang et al., 1999). In response to senescence-
inducing DNA damage agents, prohibitin localizes to specific heterochromatic foci, 
where it binds with members of the heterochromatin protein 1 (HP1) family of proteins. 
Prohibitin and HP1 bind to the E2F1-responsive proliferative promoter, leading to 
repression of E2F1 transcriptional activity (Rastogi et al, 2006). Prohibitin is able to bind 
p53 to enhance its transcriptional abilities (Fusaro et al., 2003), though it is not clear 
whether p53 functions in a positive feedback loop to activate prohibitin or an upstream 
protein is responsible. Also, p53 levels are elevated within heterozygous MEFs (Figure 
12e), indicative of senescence occurring at an earlier passage in the heterozygous MEFs. 
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Additionally, with both prohibitin and RB binding HP1 to inactivate E2F1, this suggests 
redundancy within the signaling cascade. 
Testing for the senescent phenotype in Plk4 MEFs was attempted through a P-
galactosidase staining assay. Though efforts to get the assay to work failed, as no blue 
colour indicate of senescence was observed, even though characteristics such as flattened 
morphology and increased granularity were observed in the heterozygous MEFs at an 
earlier passage than wild types. 
It is plausible that heterozygous Plk4 MEFs are senescent at an earlier passage 
than wild types, as a mechanism to prevent oncogenesis. Though no DNA replicative 
differences have been characterized between wild type and heterozygous MEFs, aberrant 
DNA replication may cause the telomeres in heterozygous MEFs to shorten at an 
accelerated rate. Therefore, the shortening of the telomeres could give cause to genetic 
instability which would lead to oncogenesis. 
Plk4 Expression in MEFs: Response to DNA Damaging Agents 
Other members of the Plk family are implicated to play crucial roles in response 
to DNA damage. In response to both ionizing radiation (IR) and ultraviolet radiation 
(UV), Plkl activity is repressed by the DNA damage sensor protein ATM and ATR, 
respectively, to inhibit Plkl from pushing cells through the cell cycle (van Vugt et al., 
2001). In contrast, Plk3 is activated by ATM in response to IR to prevent cell cycle 
progression (Xie et al, 2001), while Plk2 is activated by p53 (Shimizu-Yoshida et al, 
2001). Subsequently, Plk4 has been hypothesized to play a role in the DNA damage 
pathways, therefore Plk4 MEFs were examined in response to IR or UV. 
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i) Plk4 Transcript Abundance in Response in Ionizing Radiation 
In response to IR, for both wild type and heterozygous MEFs, the levels of Plk4 
decreased to 60 to 80% relative to the control, with no difference between the two (Figure 
9). Both wild type and heterozygous MEFs were resistant to this dose of IR, as 24 hours 
post exposure, the cells were viable. As Plk4's prominent identified role within the cell is 
centrosome duplication and dynamics (Habendanck et ah, 2005), it is likely that cell 
cycle checkpoints were enabled to ensure that any damage to the genome was repaired 
before cell growth and division ensued, coinciding with a decrease in Plk4 levels. At 8 
and 24 hours post exposure, Plk4 levels in both wild type and heterozygous MEFs started 
to increase to levels relative to the control, indicating that any DNA damage was repaired 
and the normal cellular dynamics were resuming. 
ii) Plk4 Transcript Abundance in Response to Ultraviolet Radiation 
In response to UV exposure, there was a sharp contrast observed between Plk4 
levels in the wild type and heterozygous MEFs. After UV exposure, both wild type and 
heterozygous levels decrease immediately, until 2 hours when wild type levels increased 
and continued to increase to levels greater relative to the control, 8 hours post exposure. 
In contrast, no detectable levels of Plk4 were observed in the heterozygous MEFs (Figure 
10). p53 transcriptionally represses Plk4 function (Li et al, 2005), so it is possible that 
with lower levels of Plk4 as observed in the heterozygous MEFs, the repression of Plk4 
by p53 is stronger. Furthermore, p53 protein levels are also increased in heterozygous 
MEFs in comparison to wild types in response to UV (Figure 12e). 
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Twenty-four hours post exposure to UV, both wild type and heterozygous MEFs 
were not viable, as greater than 95% of the cells were floating. It can be assumed that the 
heterozygous MEFs undergo apoptosis through a p53-mediated pathway, but for wild 
type MEFs it is difficult to make this assumption. Over-expression of Plk4 attenuates 
p53-mediated apoptosis (Li et ah, 2005) and p53 protein levels were not elevated in wild 
type MEFs in response to UV (Figure 12e), so it can be hypothesized that wild type 
MEFs undergo apoptosis through another pathway. 
iii) Plk4 Protein Levels in Response to DNA Damage 
As differences were observed in mRNA levels, it was of interest to see whether 
changes in protein levels actually corresponding to the mRNA levels. In response to both 
ER and UV, no changes were observed in Plk4 protein levels for both wild type and 
heterozygous MEFs, 6 hours post exposure. Consistent with previous studies Plk4 protein 
levels in the heterozygous MEFs were half the level observed in the wild type MEFs 
(Figure 11) (Swallow etal., 2005). 
iv) DNA Damage Protein Levels 
Proteins with known roles in the DNA damage pathways were examined in the 
MEFs to see if a difference in Plk4 gene dose would have an effect on their response to 
either IR or UV. Cdc25c is the phosphatase responsible for removing the inhibitory 
phosphates from the cyclin Bl/Cdkl complex, promoting its activation and initiating the 
G2/M transition. In response to ionizing radiation and ultraviolet radiation, Cdc25c 
activity is inhibited by Chk2 (Matsuoka et al., 1998) and Chkl (Lam and Rosen, 2004), 
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respectively. Levels of Cdc25c did not change in either wild type or heterozygous MEFs 
in response to either IR or UV (Figure 12a). 
Activation of the cyclin Bl/Cdkl complex is necessary for the G2/M transition to 
occur (Bassermann et ah, 2005). In response to DNA damage, a cell cycle block occurs at 
the G2/M transition and either the damage to the genome is repaired or the cell enters 
programmed cell death. In response to UV, levels are minimal in comparison to the 
control, indicative of a cell cycle block that would occur as the cells prepare to undergo 
apoptosis. In contrast, levels of cyclin B1 in IR exposed cells were identical to control 
levels, indicating that any DNA damage done was repaired and the cells are normally 
going through the cell cycle. Though, control and IR levels of cyclin B1 in heterozygous 
MEFs were about half of what was observed in the wild types (Figure 12d). Since no 
flow cytometry was performed to assure a normal cell cycle profile amongst the MEFs, it 
is impossible to state that there was an equal percentage of wild type and heterozygous 
MEFs at the G2/M transition. Though, the observed data is supported by previous 
findings, which showed that heterozygous MEFs have a slower growth rate which would 
be consistent with a delay entry into mitosis (Ko et al., 2005). Additionally, when 
examining hepatocytes, the appearance of cyclin B1 protein levels was delayed and 
persisted longer in heterozygous Plk4 hepatocytes than in wild types (Ko et al, 2005). 
The checkpoint kinase members Chkl and Chk2 protein levels were examined to 
observe the response elicited by DNA damage. Chkl is a signal transducer protein 
activated in response to DNA damage. In response to ultraviolet radiation, Chkl is 
activated by ATR (Abraham, 2001), allowing it to phosphorylate members of the Cdc25 
phosphatase family inhibiting there ability to promote cellular progression (Lam and 
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Rosen, 2004). Interestingly, no differences in Chkl protein levels were observed in 
response to either IR or UV (Figure 12b). Assuming a normal cell cycle profile, the 
majority of MEFs would have been present within either Gi or S phases of the cell cycle. 
Cann and Hicks, 2006 found that in response to IR, primary MEFs lack an immediate 
Gi/S checkpoint and that any response to DNA damage occurs at the level of individual 
replication origins, instead of inducing a complete shutdown of S-phase entry. This 
rationale explains why no Chkl response was elicited in the MEFs. 
Chk2 is another signal transducer protein activated in response to DNA damage. 
In response to ionizing radiation, Chk2 is activated by ATM (Matsuoka et al., 2000). 
Chk2 phosphorylates members of the Cdc25 phosphatase family inhibiting there function 
and delaying the cell cycle (Lam and Rosen, 2004). In addition, Chk2 is able to activate 
p53, allowing p53 to initiate a halt to cell cycle progression (Hirao et al., 1998). Chk2 
protein levels increased for both wild type and heterozygous MEFs in response to both IR 
and UV (Figure 12c). Elevated levels in response to UV suggest that there may be some 
cross talk in the DNA damage pathways. Previous work confirms the notion of cross talk 
between the DNA damage pathways. Cisplatin, an anticancer drug functions by inducing 
DNA cross linking in base pairs which is a similar phenotype observed in response to 
UV. Interestingly, in response to cisplatin treatment ATR and not ATM was activated 
(Pabla et al., 2007). Downstream, both Chkl and Chk2 are phosphorylated in an ATR-
dependent manner, though Chkl degradation occurs by the proteosome shortly after 
phosphorylation. Chk2 activation of p53 leads to a p53-dependent cell cycle checkpoint 
activation. In terms of the MEFs, the induction of Chk2 in response to IR probably 
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activated cell cycle checkpoints while DNA damage was repaired, while in response to 
UV, Chk2 activated p53-dependent apoptotic pathways. 
p53 is widely considered the guardian of the genome, and its expression is 
activated in response to genotoxic stresses (Efeyan and Serrano, 2007).). p53 plays a 
crucial role in the cells response to genotoxic stress by initiating DNA damage pathways. 
In response to DNA damage, p53 expression is crucial to blocking cell cycle progression 
until the DNA is repaired or apoptotic pathways are initiated (Bunz et al., 1999). In 
heterozygous Plk4 MEFs, protein levels of p53 are substantially higher than in wild 
types, with a similar scenario observed in response to UV. In response to IR, an induction 
of p53 expression is observed in wild type MEFs, while levels of p53 are constant with 
control levels for the heterozygotes (Figure 12e). There are a multitude of possible 
reasons to explain these variances. Firstly, Plk4 has been shown to phosphorylate p53 on 
serine 293 (Swallow et al., 2005). Though the significance of this interaction has yet to 
be characterized, it could be possible that the phosphorylation of p53 on this residue is 
inhibitory or that it may affect p53 stability. Based on the fact that there is only one dose 
of Plk4 present in the heterozygous MEFs, there may not be enough Plk4 present to 
inhibit p53 transcriptional activity, explaining the higher degree of p53 expression 
observed in the heterozygotes. It is also possible that the interaction between Plk4 and 
p53 maybe part of a negative feedback mechanism as p53 inhibits Plk4 through HDAC 
(Li et al., 2005) and Plk4 inhibits p53 through direct phosphorylation. The second reason 
for increased p53 levels in heterozygous MEFs may be due to the fact that aberrant 
mitotic spindle formation and chromosome mis-segregation is exhibited in heterozygous 
MEFs (Ko et al., 2005). In response to these defects, p53 is activated by the mitotic 
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spindle checkpoint causing a delay in mitotic progression (Xie et al., 2005). In addition, 
the lack of p53 induction in wild type MEFs in response to UV, suggests that apoptosis 
occurs in these cells in a p53-independent manner, while in response to IR, cell cycle 
checkpoints are established in a p53-dependent manner. 
The growth arrest and DNA damage-inducible gene (Gadd45a) expression is 
induced by DNA damage and growth arrest signals (Zhan, 2005). In response to ionizing 
radiation, Gadd45a is transcriptionally activated by p53 (Zhan et al., 1994), while 
disruption of p53 transcriptional ability inhibits Gadd45a induction (Zhan et al., 1996). In 
contrast, the induction of Gadd45a via UV is p53 independent. The induction is 
dependent on transcription factors Oct-1 and NF-YA (Jin et al., 2001). In response to 
genotoxic stress, Gadd45a is able to initiate a G2/M block on the cell cycle but is not 
necessary for the block to occur (Wang et al., 1999). Induction of Gadd45a was only 
observed in the control heterozygous MEFs and the heterozygous MEFs exposed to IR. 
In the heterozygous MEFs where p53 expression was induced, this corresponded to an 
increase in Gadd45a, except in the MEFs exposed to UV (Figure 12f). As these cells 
would eventually undergo apoptosis, as would the wild type MEFs, it is unclear whether 
Gadd45a expression is necessary. Gadd45a has been implicated to play a role in 
apoptosis (Takekawa and Saito, 1998), though it is unclear whether Gadd45a activates 
apoptosis or whether Gadd45a up-regulation occurs as a consequence of apoptotic 
response to genotoxic stress (Zhan, 2005). No induction of Gadd45a expression was 
observed in the control wild type or IR exposed wild type MEFs. As p53 expression was 
observed in the wild type MEFs exposed to IR and no Gadd45a induction was observed, 
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it is possible that p53 mechanism of inducing cell cycle checkpoints and DNA repair was 
independent of Gadd45a expression. 
Apoptotic Susceptibility in MEFs 
Wild type and heterozygous Plk4 MEFs were exposed to 40 mJ/cm2 UV and 
subjected to a TUNEL assay to determine if there was a difference in susceptibility to 
undergo apoptosis. At each of the time points examined, there was no statistical 
difference between the percentages of MEFs that stained positive for DNA fragmentation 
characteristic of apoptotic cells (Figure 13). As this experiment was performed using 40 
mJ/cm2 UV, it is unknown whether there would be a difference in percentages at a lower 
exposure rate. Subsequently, it is not known the dose of UV where the majority of MEFs 
start undergoing apoptosis. At a lower dose it could be hypothesized that there would be 
statistical differences observed with a higher percentage of heterozygous cells escaping 
apoptosis and promoting oncogenesis. This assumption is made as a microarray 
experiment comparing wild type and heterozygous MEFs exposed to 40 mJ/cm2 UV, 4 
hours post exposure showed Cdc25b as being over expressed in the heterozygous MEFs. 
Cdc25b is essential for mitotic entry when cells recover from a DNA damage checkpoint-
induced arrest (van Vugt et al., 2004). Cdc25b's requirement for mitotic entry after DNA 
damage and its involvement in tumorigenesis will be explained in further detail in the 
next section. 
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Transcript Differences in Plk4 MEFs: Response to Ultraviolet Radiation 
Transcriptional differences were observed in Plk4 mRNA transcript profiles 
between wild type and heterozygous MEFs upon exposure to UV. Therefore, it was of 
interest to gain a further understanding of differences in the transcript profiles of 
additional genes within the Plk4 MEFs. Microarray analysis was performed comparing 
wild type and heterozygous MEFs 4 hours post UV exposure. It was discovered that 27 
genes presented at least a two fold decrease in transcript profile in the heterozygous 
MEFs (Table 3), while 84 genes had a least a two fold increase in transcript profile in the 
heterozygous MEFs (Table 4). As stated above, by far the most unique finding from the 
microarray data was Cdc25b being over expressed in the heterozygous MEFs. 
Cell division cycle 25b (Cdc25b) is a member of the Cdc25 phosphatase family 
that plays a major role in the cell cycle control by dephosphorylating and activating 
cyclin-dependent kinases at stages during the cell cycle (Burgler et al., 2006). Cdc25b 
plays a role in mitotic entry though its function is dispensible (van Vugt et al., 2004). 
Ferguson et al., 2005 showed that mice lacking Cdc25b were normal for development, 
cell cycle and DNA damage response and that Cdc25a or additional phosphatases could 
compensate for its loss. In contrast, Cdc25b function is essential for resuming the cell 
cycle after DNA-damage cell cycle arrest (van Vugt et ah, 2004). Re-entry of the cell 
cycle is also reliant on Plkl-dependent degradation of Weel (Watanabe et al., 2004), 
which phosphorylates and inhibits the CDKs. Removal of Weel allows Cdc25b to more 
efficiently dephosphorylate and activate cyclin B1/CDK1 (van Vugt et al., 2004). 
Additionally, over expression of Cdc25b can lead to the accelerated exit of cells from the 
G2/M transition after the checkpoint has been activated. Though, this acceleration can be 
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reversed by inhibiting the catalytic activity of Cdc25b using pharmalogical inhibitors 
against Cdc25 (Bugler et al, 2006). 
Cdc25b has been identified as being over expressed in a number of human 
cancers including head and neck cancer (Gasparotto et al., 1997), non-small cell lung 
cancer (Wu et al, 1998) gastic cancer (Kudo et al., 1997), non-Hodgkins lymphoma 
(Hernandez et al., 1998), colon cancer (Takemasa et al., 2000), esophagus cancer 
(Nishioka et al., 2000), breast cancer (Cangi et al., 2000), and ovarian cancer (Broggini et 
al., 2000). In these types of cancers, over expression of Cdc25b correlated with a higher 
degree of malignancy and a poorer prognosis for the patient (Kristjansdottir and Rudolph, 
2004). 
In addition, in an examination of hepatocellular carcinomas (HCC), Cdc25b was 
one of the most significantly over expressed genes in comparison to non-tumor liver 
tissue (Chen et al., 2002); while silencing of Cdc25b expression in HCC cell lines has 
been shown to prevent cell proliferation, migration and invasion and delay xenograft 
growth (Yan et al, 2008). 
It can be hypothesized that over expression of Cdc25b in heterozygous Plk4 mice 
could contribute to the increased tumorigenesis observed. In response to DNA damage, 
cell cycle checkpoints are employed to repair any damage to the genome. Loss of an 
upstream tumor suppressor which targets Cdc25b and Plkl for repression would 
contribute to Cdc25b and Plkl initiating re-entry to the cell cycle without errors in the 
genome being repaired. Combined with the heterozygous Plk4 MEFs and hepatocytes 
displaying aberrant spindle formation and abnormal chromosome segregation during 
mitosis (Ko et al., 2005), it is plausible that these factors could contribute to cellular 
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transformation leading to an oncogenic state. It will be interesting to examine Cdc25b 
mRNA and protein levels within heterozygous liver tumors in comparison to normal 
tissue within both wild type and heterozygous liver samples to see if there is an 
observable difference in Cdc25b levels. If Cdc25b levels are elevated within 
heterozygous liver tumors, it provides a possible explanation for increased liver tumor 
incidence within heterozygous Plk4 mice. 
In comparison of the microarray data between normal wild type and heterozygous 
MEFs and Plk4 MEFs exposed to UV, six genes were over expressed in heterozygous 
MEFs within both data sets. This indicates that these genes are over expressed in 
heterozygous MEFs in normal pathways and in response to DNA damage. These genes 
include T-cell factor 4, villin 1, fetal alzheimer antigen, thromospondin, transducin-like 
enhancer of split 1 and sal-like 3. 
The T-cell factor/ lymphocyte enhancing factor (TCF/LEF) are a family of 
transcription factors involved in the Wnt signaling pathway (Polakis, 1999). B-catenin 
binds TCF4 to activate its transcriptional activity in Wnt signaling and TCF4 has been 
implicated in neural and limb development (Cho and Dressier, 1998). TCF4 has been 
shown to transcriptionally activate cell cycle regulating genes such as cyclin Dl and c-
myc. As stated above, TCF4 over expression has been implicated in the development of 
hepatocellular carcinoma (Zhao et al., 2004). As numerous Wnt genes and their targets 
over expression has been characterized in hepatocellular carcinoma, it is possible that 
aberrant Wnt regulation could be a contributing factor in the development of liver tumors 
in heterozygous mice. 
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Villin 1 has been characterized as an actin-binding protein associated with the 
striated border of simple columnar epithelium in the body. Villin is believed to function 
in the bundling, nucleation, capping, and severing of actin filaments, though its exact 
function is unknown (Friederich et al., 1999). Since the exact cellular function of villin 
has yet to be fully characterized, it is difficult to speculate as to the exact implications 
over expression of villin may have in heterozygous MEFs. 
Fetal alzheimer antigen (FAC1) was first characterized as being developmentally 
regulated in the cortex of the brain (Bowser et al., 1995). Subsequent results show FAC1 
as a DNA binding protein capable of functioning as a transcription factor (Jordan-Sciutto 
et al, 1999), and capable of inducing apoptosis by activating caspase 3 (Strachan et al., 
2005). Over expression of FAC1 in heterozygous MEFs exposed to UV is rational as 
these MEFs undergo apoptosis due to UV exposure. Given FACl's role to activate 
caspase 3 and initiate apoptotic pathway in normal heterozygous MEFs, it possible to 
speculate that there is genomic instability within these cells that would mediate the 
initiation of these pathways. Since the heterozygous MEFs continue to divide, it is also 
possible that some downstream effector inhibits these apoptotic pathways, continuing the 
presence of genomic instability leading to cellular transformation. 
Thrombospondin is a crucial inhibitor of angiogenesis (Volpert et al., 1997) 
whose expression is positively regulated by p53 (Dameron et al., 1994). p53 mutations 
have been extensively characterized in hepatocellular carcinomas (Aguilar et al, 1994). 
Therefore it is possible that loss of or a mutation in p53 would inhibit thrombospondin 
from prevent angiogenesis and allowing tumor formation to occur. It would be interesting 
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to examine levels of both p53 and thrombospondin in hepatocellular carcinomas in 
heterozygous mice to see if this hypothesis is true. 
Transducin-like enhancer of split 1 (TLE1) or Groucho-related gene 1 (GRE1) is 
a member of the Notch signaling pathway that is a transcriptional repressors of Wnt 
signaling and other cell fate determination signals (Liu et al., 1996). In a study examining 
dedifferentiation from a well-differentiated tumor to a moderately-differentiated tumor in 
hepatocellular carcinomas (HCC), TLE1 was discovered as being over expressed 
(Midorikawa et al., 2002). TLE1 over expression in HCC may provide for an additional 
mechanism for tumor formation within heterozygous Plk4 mice. In addition, Allen et al., 
2006 used a mouse model to examine TLE1 over expression. TLE1 over expression 
induced lung adenocarcinoma formation with reduced levels of p53 and increased levels 
of the receptor tyrosines kinases ErbBl and ErbB2. Interestingly, in Plk4 heterozygous 
mice, the second most common site of tumor formation was the lung, with the tumors 
characterized as adenocarcinomas (Ko et al., 2005). TLE1 over expression and p53 down 
regulation may provide a mechanism for lung tumor formation in heterozygous Plk4 
mice. 
Sal-like 3 (SALL3) is a homologue of the Drosophila splat gene which is required 
for development of the head and tail segments in an organism (Kohlhase et al., 1999). 
Loss of SALL3 expression leads to embryonic lethality from failure of cranial nerve 
formation from the hindbrain (Parrish et al, 2004). Beyond this information, little is 
known about SALL3 and its functional role within the cell. Therefore it is difficult to 
make an assumption to the exact role that SALL3 over expression plays within 
heterozygous MEFs. 
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Transcriptional Difference between Normal & UV Wild Type and Normal & UV 
Heterozygous MEFs 
To gain an understanding of the transcriptional differences between normal and 
UV exposed MEFs, the two previous microarray data sets were compared. It was 
discovered that 171 genes were up-regulated in normal wild type MEFs (Table 5), while 
83 genes were down-regulated in the normal wild type MEFs (Table 6). 151 genes were 
observed to be up-regulated in normal heterozygous MEFs (Table 7), while 24 genes 
were down-regulated in the normal heterozygous MEFs (Table 8). In addition, there were 
a number of common genes that were up-regulated in both the normal wild type and 
normal heterozygous MEFs. Similarly, there were common genes within the UV wild 
type MEFs and the UV heterozygous MEFs. The differences in the genes that were up-
regulated in both the wild type and heterozygous MEFs provide additional clues to 
possible mechanistic differences, explaining the phenotypic differences observed 
between wild type and heterozygous MEFs. Likewise, differences observed between the 
UV wild type MEFs and UV heterozygous MEFs could provide mechanistic pathways to 
explain possible differences in the MEFs response to ultraviolet radiation. 
While this analysis may provide a general survey of the differences between 
normal and UV exposed MEFs, without secondary validation using northern analysis, 
RT-PCR or real-time PCR, the validity of the results remains debatable. Proper statistical 
microarray analysis was unable to be performed due to software limitations with the 
TIGR software suite. The microarray analysis was performed manually using comparing 
raw intensity, so it is possible that errors could have been made. 
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Future Directions 
It is necessary to determine the function significance of the interaction between 
Plk4 and p53. Plk4 is able to phosphorylate p53 on Ser-293 (Swallow et al., 2005). Ser-
293 is within the DNA-binding domain of p53 (Bell et al., 2002). It is hypothesized that 
Plk4 and p53 interact through a feedback mechanism and p53 is able to repress Plk4 
function through HDAC. It is assumed that over-expressing Plk4 causing 
phosphorylation of Ser-293 will inhibit p53's ability to bind the TATA box binding 
protein to facilitate the recruitment of HDAC to repress Plk4. Additionally, it is of 
interest to determine how the phosphorylation of Ser-293 affects the conformational 
structure of p53 and how this affects its function. Furthermore, it is of interest to 
investigate how the phosphorylation of Ser-293 affect protein levels of known 
downstream p53 targets and that this phosphorylation could affect p53 function in 
multiple signaling cascades. Elucidating the functional interaction between p53 and Plk4 
will provide a more thorough incite to the observed phenotypic differences between wild 
type and heterozygous MEFs. This interaction may provide a clue as to why 
heterozygous Plk4 mice develop cancer at a rate twenty times greater than wild types. 
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